Characterization and functional regulation of bioactive peptides in avian macrophages and heterophils by Kannan, Lakshmi
University of Arkansas, Fayetteville
ScholarWorks@UARK
Theses and Dissertations
12-2009
Characterization and functional regulation of
bioactive peptides in avian macrophages and
heterophils
Lakshmi Kannan
University of Arkansas
Follow this and additional works at: http://scholarworks.uark.edu/etd
Part of the Biochemistry Commons, Cell Biology Commons, and the Molecular Biology
Commons
This Dissertation is brought to you for free and open access by ScholarWorks@UARK. It has been accepted for inclusion in Theses and Dissertations by
an authorized administrator of ScholarWorks@UARK. For more information, please contact scholar@uark.edu.
Recommended Citation
Kannan, Lakshmi, "Characterization and functional regulation of bioactive peptides in avian macrophages and heterophils" (2009).
Theses and Dissertations. 182.
http://scholarworks.uark.edu/etd/182
 
  
 
 
 
 
 
 
 
 
CHARACTERIZATION AND FUNCTIONAL REGULATION OF BIOACTIVE 
PEPTIDES IN AVIAN MACROPHAGES AND HETEROPHILS 
 
 
  
 
 CHARACTERIZATION AND FUNCTIONAL REGULATION OF BIOACTIVE 
PEPTIDES IN AVIAN MACROPHAGES AND HETEROPHILS 
 
 
 
 
 
 
 
 
 
 
A dissertation submitted in partial fulfillment 
of the requirements for the degree of 
Doctor of Philosophy in Cell and Molecular Biology 
 
 
 
 
 
 
 
By 
 
 
 
 
 
 
 
LAKSHMI KANNAN 
University of Madras 
Bachelor of Science in Chemistry, 2002  
University of Madras 
Master of Science in Biotechnology, 2004 
 
 
 
 
 
 
 
December 2009 
University of Arkansas 
ABSTRACT 
Oligopeptides and low molecular weight polypeptides play central roles as 
effectors and signal transducers acting as hormones, neurotransmitters, growth factors, 
toxins, and antimicrobial factors that are important for the survival of the organism.  
Owing to the ubiquitous involvement of peptides in many key regulatory processes, we 
have been interested to identify native peptides in different cells and tissues and 
understand their functions. To conduct our studies, we used avian macrophages and 
heterophils as models of specialized cells which constitute central components of innate 
immunity. These studies involved (a) qualitative identification and characterization of the 
peptides associated with high intensity mass spectral peaks in macrophage and heterophil 
and (b) the quantitative changes in those peptides under immunomodulating effects of 
toll-like receptor (TLR) activators. The work presented here describes the identification 
of thymosin beta 4 (Tβ4), an actin binding peptide, in macrophages and its modulation 
under TLR activation. This dissertation also includes identification of mature avian beta 
defensin 2 (AvBD2), an antimicrobial peptide in heterophils of 4 different avian species 
(chicken, turkey, pheasant and quail) and its modulation in chicken heterophils under 
similar conditions.  
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INTRODUCTION 
Cellular identities are often determined by a repertoire of proteins and peptides 
which make up their structural components and govern their specialized functions. 
Therefore, despite genomic unity amongst different cell and tissue types of an organism 
they emanate proteomic diversities. In recent years there has been major emphasis in 
proteomics to study and understand the individual proteins, their modifications, and 
functions in relation to development, differentiation, metabolism, and disease. While 
significant developments have taken place in the analysis of proteins, particularly using 
2D gel electrophoresis, similar developments for the analysis of low molecular weight 
peptides are lagging behind. It is because peptides are less amenable to 2D analysis and 
conventional proteomic procedures. Oligopeptides and low molecular weight 
polypeptides play central roles as effectors and signal transducers acting as hormones, 
neurotransmitters, growth factors, toxins, and antimicrobial factors that are important for 
the survival of the organism. Owing to the ubiquitous involvement of peptides in many 
key regulatory processes, we have been interested to identify native peptides in different 
cells and tissues and understand their functions. We have used avian heterophils and 
macrophages as models of specialized cells which constitute central components of 
innate immunity to conduct our studies. These cells share many common features such as 
they respond to similar microbial stimuli, exhibit chemotaxis, engulf microbial 
pathogens, and produce many identical cytokines and metabolites to maintain immune 
homeostasis. Yet, these cells also differ in many ways with respect to their morphology, 
physiology, longevity, priming adaptive immunity, and also in the pattern of their 
response to inflammatory stimuli. To understand the similarities and differences in the 
 2 
peptide profiles of these cells, we used matrix assisted laser desorption/ionization-time of 
flight (MALDI-TOF) mass spectrometry which has proved to be a formidable tool to 
analyze biomolecules. Using whole cells or their extracts, the studies in this dissertation 
involves both qualitative and quantitative characterization of molecules associated with 
high intensity mass spectral peaks in macrophage and heterophils. Thus, the study in this 
dissertation is divided into two categories with specific objectives in each. The categories 
are: (A) qualitative identification and characterization of the peptides associated with 
high intensity mass spectral peaks in macrophage and heterophil and (B) study the 
quantitative changes in those peptides under immunomodulating effects of toll-like 
receptor (TLR) agonists which activate these cells. The work presented here describes 
identification of thymosin beta 4 (Tβ4), an actin binding peptide in macrophages and its 
modulation by toll-like receptor activation, and the identification of mature avian beta 
defensin 2 (AvBD2), an antimicrobial peptide in heterophils of 4 different avian species 
and its modulation in chicken heterophils under similar conditions.  
Based on the two categories, the dissertation is divided into six chapters including 
the literature review. Chapters 2-4 submit to the identification and characterization of 
differentially associated peptides such as thymosin beta 4 and avian beta defensin 2 in 
avian macrophages and heterophils respectively, and the chapters 5 and 6 include the 
regulation of these peptides by toll-like receptor activation. 
Chapter 1: Peptidomic Perspective of Avian Biology: A Literature Review  
Chapter 2: Identification and Characterization of Thymosin Beta 4 in Chicken 
Macrophages using Whole Cell MALDI-TOF (Ann. N. Y. Acad. Sci. 1112: 424-434, 
2007). 
 3 
Chapter 3: Direct Screening Identifies Mature Beta Defensin 2 in Avian Heterophils 
(Poult. Sci. 88(2):372-9, 2009). 
Chapter 4: A Direct MALDI MS Study to Identify Avian Beta Defensin 2 (AvBD2) 
from Pheasant and Quail Heterophils (Submitted to Journal of Proteome Research). 
Chapter 5: Effect of Toll-Like Receptor Activation on Production of Thymosin Beta 4 
by Chicken Macrophages (In internal review). 
Chapter 6: Evaluation of Beta Defensin 2 Production by Chicken Heterophils using 
Direct MALDI Mass Spectrometry (Mol Immunol. 46(15):3151-6, 2009). 
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PEPTIDOMIC PERSPECTIVE OF AVIAN BIOLOGY: A LITERATURE 
REVIEW 
 
INTRODUCTION 
Peptides are strings of amino acids covalently linked through secondary amide or peptide 
bonds which include dipeptides, oligopeptides to as long as 100 amino acid stretch 
polypeptides that can be loosely classified as low molecular weight proteins (Norbert and 
Hans-Dieter, 2003a; Petra and Harald, 2007). The oligopeptides and polypeptides play 
many central roles in maintenance of homoeostasis regulating many metabolic and 
physiological functions essential for the survival of organism (Norbert and Hans-Dieter, 
2003b). For instance, tripeptide glutathione takes part in intermediary metabolism and 
acts as an antioxidant (Martin and Teismann, 2009). Ubiquitin which regulates many 
cellular processes such as protein sorting, inflammation and proteosomal degradation is a 
widely occurring 8.5 kDa polypeptide (Ramage et al., 1994). Many oligopeptides and 
polypeptides serve as signaling and growth factors acting as hormones (ghrelin, 
urotensin, obestatin), and neurotransmitters (opioid peptides, vasopressin, angiotensins, 
bradykinins). These peptides function in autocrine, endocrine, or paracrine fashions 
(Konig, 1996). Others such as toxins and antimicrobial peptides are designed to function 
as defense factors protecting the organism. Most of these polypeptides are produced or 
stored in specific cells and tissues and are released upon physiological exigencies. The 
instantaneous actions of peptides are presumably suited through their low molecular mass 
that allows their easy access into cell environments to participate in physiological 
mechanisms. The peptides are classified as ribosomal, non-ribosomal, and peptide 
fragments, depending on how they are produced (Petra and Harald, 2007). Most peptides 
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in higher organisms that play important role as effector molecules and signal transducers 
are ribosomal produced by the translation of mRNA. Similar to proteins, they also 
undergo posttranslational modifications such as phosphorylation, acylation, amidation, 
glycosylation, sulfonation and disulfide bond formation (Baggerman et al., 2004). By 
contrast, non-ribosomal peptides are synthesized by modular enzyme complexes called 
nonribosomal peptide synthetases and are commonly found in unicellular organisms, 
plants, and fungi (Schwarzer et al., 2003). Peptides are also generated by proteolysis of 
larger proteins during physiological or pathological processes. For example, neutrophil 
invasion, and metastatic cancer cell migration induce tissue proteolysis generating protein 
fragments (Geho et al., 2005; Romero et al., 1991). Also aberrant quantities of peptides 
can be produced in the course of disease processes such as in Alzheimer’s (Nilsson et al., 
2001) or neoplastic transformation that are likely to be found in body fluids which have 
been exploited as diagnostic markers for specific diseases (Schrader and Selle, 2006).  
In addition to the native occurrence of many biologically active peptides in cells 
and tissues that function as hormones and neurotransmitters, bioactive peptides can also 
derived artificially from food/biological sources by proteolysis of larger proteins. These 
polypeptides have received much attention because of their specific biological activities 
and pharmacological properties as antioxidative, antimicrobial, anticancer or 
immunomodulatory efficacies (Fields et al., 2009; John Howl, 2009; Mine, 2007; Norbert 
and Hans-Dieter, 2003a). However, most cell/tissue-associated peptides are naturally 
occurring and are synthesized in the cell in the form of large prepro forms, which are then 
cleaved and modified, by selective action of peptidases to give biologically active 
products in their mature forms (Fricker et al., 2006; Hook, 1998). Owing to ubiquitous 
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involvement of peptides in many key regulatory processes, we have been working with 
the hypothesis that different cells and tissues exhibit their own repertoire of low 
molecular proteins/peptides that contribute to their specialized functions. Hence, 
identifying and characterizing these native mature peptides will not only provide insight 
into their functional physiology involving development, differentiation, metabolism, and, 
their disease related changes but also to prospect for their bioactivities in relation to their 
clinical applications. Compared with mammalian species, the analysis of low molecular 
weight (LMW) proteins or bioactive peptides in avian cells and tissues are lagging 
behind.  To date, very few peptides, less than 100 amino acids, have been identified in 
avian species most of which are largely limited to chicken. Many of these peptides 
belong to neuropeptide, neuroendocrine signaling pathways such as vasotocin, 
gonadotropin or corticotrophin releasing hormones in the brain (Takahashi et al., 1992; 
Troskie et al., 1997), galanin (Norberg et al., 1991), gastrin releasing peptide (McDonald 
et al., 1980) (Campbell et al., 1990), neuromedim-U-25 (Domin et al., 1992), neurokinin 
A (Conlon et al., 1988), motilin (De Clercq et al., 1996), Subtance-P (Conlon et al., 1988) 
that have been isolated from chicken intestine. Others include host defense related 
antimicrobial peptides such as beta defensins and fowlicidins present in chicken myeloid, 
epithelial cells, and liver (Harmon, 1998; Harwig et al., 1994; Lynn et al., 2004; Xiao et 
al., 2006; Xiao et al., 2004). Also mineral homeostasis maintaining calcitonin and 
parathyroid hormones (Homma et al., 1986; Khosla et al., 1988), play central roles in 
avian skeletal biology. Despite identification of few such peptides there is paucity of 
information about the identities and functions of many other polypeptides that occur 
naturally in the cells of avian species. Thus, characterization of native peptides and their 
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changes has potential to provide better understanding under a variety of physiological and 
pathological conditions.  
PROTEOMICS IN POST-GENOMIC ERA 
Among the avian species, chicken is the first livestock animal to enter the post 
genomic era and has reached the status of model organism, since the publication of 
chicken genome sequence and the development of high-throughput tools for functional 
genomics (Burt, 2004; Cogburn et al., 2007; Dodgson, 2007). Functional genomics refers 
to the study of function and regulation of gene and gene products on a global level. 
Although genomic technologies such as DNA microarrays are available to study gene 
products in the form of mRNAs, analyzing gene expression on the transcript level and 
extrapolating this data to the protein or peptide level is not sufficient. That is because of 
the differential mRNA translation, alternative splicing or post-translational modifications 
of proteins/peptides. Such changes that are not apparent from the DNA sequence can be 
determined only by proteomic and peptidomic methodologies and thus verification of a 
gene product by these methods is an important step in “annotating the genome” (Cogburn 
et al., 2007).  
Proteomics, a new discipline in functional genomics involves study of proteins in 
cells, tissues, or body fluids. Thus, since the sequencing of the genome, there has been 
increasing number of reports on proteomic studies to understand the molecular basis of 
chicken’s normo- and pathophysiology. Some reports include protein profiling in the 
facial development of chicken embryo (Mangum et al., 2005), skeletal muscles (Doherty 
et al., 2004), eye lens (Wilmarth et al., 2004), chicken germ line stem cells (GSCs) (Han 
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et al., 2009), whole organ bursa of Fabricius (McCarthy et al., 2006) and the analysis of 
chicken serum proteome (Huang et al., 2006). Also, different parts of chicken egg such as 
egg yolk plasma, vitelline membrane, calcified eggshell layer and egg white have been 
well characterized by proteomic analysis (Mann, 2007; Mann, 2008; Mann et al., 2006; 
Mann and Mann, 2008). Though proteome research in the chicken is still rudimentary 
stage, similar studies at the peptidomic level are under developed. Therefore, like 
proteins, it is necessary to understand the native peptides of cells and tissues in health and 
disease that also contribute to the fundamentals of chicken genome’s functional capacity.   
SCOPE OF PEPTIDOMICS 
The term peptidomics refers to the comprehensive qualitative and quantitative 
analysis of LMW proteins/peptides present in the biological system, thus covering the 
gap between proteomics and metabolomics (Clynen et al., 2001; Schulz-Knappe et al., 
2005; Soloviev and Finch, 2006). Although there has been a rapid development in 
proteome research over the last few decades, “peptidomics” in general, is under explored. 
The development of gel electrophoresis techniques for separation of proteins has been of 
great importance especially to the development of protein-derived drugs. However, the 
gel based systems have been less efficient for recovering components with molecular 
weights below 10 kDa, because of low resolution (Baggerman et al., 2004). Hence, 
research on naturally occurring low molecular weight polypeptides has not progressed 
sufficiently.  Also, in this context it is easy to understand why conventional proteomics 
has focused on proteins rather than on small and mature forms of peptides. Since there 
are many peptides that are abundant in biological fluids, cells and tissues yet unknown, 
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there is a strong interest and need for rapid and less laborious approaches to identify and 
quantify native peptides.  
Traditionally identification of peptides mostly involved separation techniques 
such as affinity chromatography, size exclusion chromatography, and multiple high 
performance liquid chromatography (HPLC) fractionation steps followed by detection via 
immunoassay techniques, and elucidation of primary structure by Edman sequencing. 
However, all of these methods for identification are considered laborious. The advent of 
genome projects, advancement in proteomic tools such as mass spectrometry (MS), 
improved separation techniques such as nanoscale HPLC, and bioinformatics has paved 
way for peptidomics to analyze LMW proteins/peptides in complex mixtures. Therefore, 
the current trend in peptidomics is largely based on MS, enabling simultaneous mass and 
sequence determination of peptide (Petra and Harald, 2007). A mass spectrometry is an 
analytical technique used to determine the molecular mass of a sample based on the 
mass-to-charge (m/z) ratio of charged ions. Different kinds of mass spectrometers exist 
and the two main technologies used for peptidomic research (both qualitative and 
quantitative analysis) include matrix-assisted laser desorption ionization-time of flight- 
mass spectrometry (MALDI-TOF-MS) and the electrospray ionization MS coupled with 
reversed phase HPLC (LC-ESI-MS) (Baggerman et al., 2004; Clynen et al., 2003; 
deHoffman, 2003). One of the major challenges for analysis of peptides in crude mixtures 
such as biological fluids is the interference by lipids, ions, and other small molecules. 
Some of these aspects can be surmounted using fractionation procedures such as liquid 
chromatography, capillary electrophoresis techniques (Guerrera and Kleiner, 2005).  
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Qualitative analysis 
 Identification and characterization of targeted proteins/peptides involve two types of 
analysis; (a) peptide mapping or peptide mass fingerprinting which refers to the analysis 
of intact peptide masses generated by enzyme digestion and (b) or analysis of peptide 
fragment ions for similar algorithm based in silico digestion and or de novo sequencing of 
novel peptides (Twyman, 2004). Also, identification of peptides in cells and tissues using 
whole cells, tissues or their extract are gaining momentum due to the advancement in 
direct mass spectrometric profiling by MALDI-TOF-MS. The direct analysis include 
identification of the mature forms of native peptides in whole cell/tissue/organs which is 
also accomplished by techniques called MALDI imaging where a spatial distribution of 
peptides in the tissues is observed (Chaurand et al., 1999). There are several reports on 
such direct analysis in both invertebrate and vertebrate species which have lead to studies 
and discoveries of novel neuropeptides and their relation to behavior and physiology 
(DeKeyser and Li, 2006; Dong et al., 2009; Herring et al., 2007; Hummon et al., 2006; Li 
et al., 2000; Ma et al., 2009; Yuan and Desiderio, 2005). In addition to MALDI, ESI MS 
is another powerful technique that can fragment even femtomole amounts of peptides 
with high efficiency making it an ideal tool for amino acid sequencing (Clynen et al., 
2003). Nano LC coupled with ESI-TOF MS, has been used to unravel peptidome of the 
nervous system of drosophila (Baggerman et al., 2002), the rat brain (Skold et al., 2002), 
and the human urine samples (Heine et al., 1997). The advancement in peptide discovery 
is further accomplished using tandem mass spectrometry (MS/MS) such as collision 
induced dissociation and post source decay, coupled to MALDI or ESI which favors 
structural and sequence determination of peptides because of its efficiency, accuracy and 
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sensitivity (Cape et al., 2009). This has lead to the finding of several peptides such as 
insulin-related peptides (de With et al., 1997), small cardioactive peptides (Jimenez et al., 
1998), and several neuropeptides (Cape et al., 2009; Ons et al., 2009).  
  Using such formidable tools, peptide discovery in avian species has been 
increasing over the years. For instance, the isolation and characterization of antimicrobial 
peptides from avian heterophils (Evans et al., 1994), chicken liver (Li et al., 2007), and 
identification of avian beta defensins from king penguin and ostrich (Sugiarto and Yu, 
2006; Thouzeau et al., 2003) were accomplished using MS. Myers and Patnoy  (2006) 
developed a new strategy utilizing electrospray-ionization mass spectrometry for the 
qualitative determination of gonadotropin releasing hormone (GnRH) peptides in several 
species including chicken I and chicken II GnRH peptide. They also demonstrated by de 
novo sequencing of intact GnRH peptides and by using ESI-MS/MS proposed adequate 
sequence coverage for these peptides (Myers and Patonay, 2006).  
 
Quantitative analysis 
Quantitative peptidomics is an additional dimension to peptide identification and 
characterization when it is required to know the peptide abundance in the sample. Similar 
to quantitative proteomics, the peptidomic approaches also involve mass spectrometry 
although it was realized that MS could not be simply used for quantification because it is 
not inherently a quantitative technique (Yan and Chen, 2005). However recent advances 
in stable isotope labeling methods, MS instrumentation, and bioinformatic analysis have 
facilitated platforms to obtain quantitative information about the peptide components of 
the cell. Comparing various conditions such as two disease states or the effects of genetic 
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knockout, the stoichiometry of proteins/peptides in a large complexes or monitoring 
changes to a proteome/peptidome over time has been accomplished (Brockmann et al., 
2009; Che and Fricker, 2005; Che et al., 2006).  The quantitative approaches solely based 
on signal intensities of spectral peaks have been difficult.  However, combining sample 
preparations such as affinity matrices (lectins) C18 matrix based isolation of peptides free 
of salts and ions and the use of novel algorithm based softwares the detection of 
quantitative difference detection are becoming feasible (Chernokalskaya, 2006). 
Besides, the advent of new approaches such as stable isotope labeling of 
proteins/peptides have facilitated mass spectrometry based quantification and the various 
approaches are discussed in detail in reviews by different research groups (Bantscheff et 
al., 2007; Ong and Mann, 2005; Yan and Chen, 2005). Stable isotope labeling of proteins 
was first introduced by Gygi and his research team in 1999 using isotope coded affinity 
tags (ICAT) (Gygi et al., 1999). Since then, many groups have adopted the principle of 
this strategy creating specific mass tags using differential stable isotopes which can be 
introduced into proteins or peptides metabolically, chemically, or enzymatic labeling 
such as SILAC, 18O labeling, isobaric tag for relative and absolute quantitation (iTRAQ), 
isotope coded protein labeling (ICPL) (Fenselau and Yao, 2009; Ong et al., 2002; 
Schmidt et al., 2005; Shevchenko et al., 1997; Wiese et al., 2007). By measuring the 
signal intensities of light and heavy isotope tagged peptides in the same spectrum, the 
quantitative differences can be calculated under different conditions. Metabolic labeling 
by stable isotope labeling of amino acids in cell culture (SILAC) was introduced by 
Matthias Mann’s group in 2002 has been used in many studies (Ong et al., 2002; Ong and 
Mann, 2007). By contrast, label-free quantification correlates to the mass spectrometric 
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signal of intact proteolytic peptides or the number of peptide sequencing events with the 
relative or absolute protein quantity directly (Asara et al., 2008; Wang et al., 2008). Thus 
different MS-based approaches have been generated with their own strengths and 
weaknesses (Moritz and Meyer, 2003) and the most commonly used MS tools for 
quantification of proteins and peptides are ESI or MALDI. Additionally, protein array 
based quantification similar to DNA microarray technology, also exists to detect and 
quantify proteins interacting with individual target proteins however, this method does 
not majorly rely on MS (Stoevesandt et al., 2009). Thus, most of the MS strategies are 
promising because they can reveal cell/tissue associated mature and functional peptides 
on both qualitative and quantitative basis.  
 
AVIAN MACROPHAGES AND HETEROPHILS 
Native bioactive peptides are more often than not, are produced by cells and 
tissues that play active roles in homeostasis such as neural, endocrine, and immune cells. 
While significant developments haven taken place in the analysis of neural and endocrine 
peptides, similar studies with immune cells are less explored. Multicellular organisms 
have evolved various defense mechanisms for protection against microbial invasions. 
Phagocytes such as the macrophages and neutrophils are principal cells responsible for 
innate immunity (Scott and Frank, 2009).  As the first line of defense against pathogen 
invasion, these cells have the ability to be mobilized for migration to the site of 
inflammation and counter pathogens or foreign components by producing factors to 
prevent their spread.  In the process, these cells engulf pathogens. The macrophages also 
ingest apoptotic neutrophils thereby removing inflammation (Kennedy, 2009). In birds, 
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the heterophils (neutrophil equivalent) and macrophages are major phagocytes (Juul-
Madsen et al., 2008). These cells play essential roles in all aspects of multicellular life 
ranging from inflammation and defense against pathogens to wound healing, 
development and tissue remodeling. They initiate immune response through cell 
signaling cascade by expression of effector molecules including chemokines, cytokines 
and other secretory factors such as anti-inflammatory or anti-microbial peptides (Juul-
Madsen et al., 2008; Kogut et al., 2005; Kogut et al., 2006; Qureshi, 2003). The immune 
responses in these cells are predominantly triggered by their ‘pattern recognition 
receptors’ (PRR), which are transmembrane or cytoplasmic proteins that identify the 
microbial pathogens or their derived products known as ‘pattern associated molecular 
patterns’ (PAMPs) (Janeway and Medzhitov, 2002). Thus, in recent years, an increasing 
number of pattern recognition receptors (PRRs), has been described to participate in 
innate recognition of microbes, through PAMPs evoking the production of effector 
molecules. Different kinds of PRRs such as Toll-like receptors (Sabroe et al., 2003), 
NOD-like receptors (Inohara and Nunez, 2003), glucan receptors and mannose receptors 
exist (Apostolopoulos and McKenzie, 2001), specific to cell types. Both TLRs and NOD 
receptors induce signal cascade mechanisms triggering the expression of pro 
inflammatory and co-stimulatory molecules and are thus involved in a variety of 
functions in regulation of inflammatory and apoptotic responses. Other receptors such as 
glucan and mannose PRRs triggers endocytosis and phagocytosis of the microbe and do 
not rely on signaling mechanisms. At present, TLRs have been found in many species 
ranging from insects to mammals (Sabroe et al., 2003). In birds, so far chicken is the only 
species where 10 TLRs have been reported to be expressed in a wide range of tissues 
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(Boyd et al., 2007; Temperley et al., 2008) whereas, NOD-like, mannose and glucan 
receptors are not well characterized in chickens unlike mammalian genome (Juul-Madsen 
et al., 2008). 
To understand the function of these cells, it is necessary to know the proteins and 
peptides involved, which are the active and functional product of most genes. Over the 
years, there has been considerable research at protein level in these cells as evident from 
the reports of different research teams that has contributed to the establishment of 
functional profile of the neutrophil and macrophage proteome in mammals (Gadgil et al., 
2003; Kang et al., 2009; Lominadze et al., 2006; Piubelli et al., 2002). However, to date 
we know of no reports on proteomic studies related to avian immune cells although an 
immunoproteomics program was developed at Mississippi State University (MSU) 
College of Veterinary Medicine by Dr. Burgess and his research group in January 2002 
(Burgess, 2004). While significant developments have taken place in the analysis of 
macrophage or neutrophil proteome, similar analysis at peptidome level is in nascent 
stage on global scale including mammals. In general, knowledge on the database of 
peptides in immunology is very limited except for certain peptides such as thymopoietin I 
and II in the induction of early T cell differentiation (Goldstein, 1974; Sunshine et al., 
1978), thymosin α1 in T cell differentiation (Bach et al., 1979; Deber et al., 1980) and 
antimicrobial peptides in host defense mechanisms. In birds, antimicrobial peptides such 
as avian beta defensins and fowlicidins are the widespread immune related LMW native 
peptides identified mostly in heterophils of chickens including few in other species of 
birds (Lynn et al., 2007; Sugiarto and Yu, 2006; Thouzeau et al., 2003; van Dijk et al., 
2008; Xiao et al., 2004).  
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CURRENT AND FUTURE PROSPECTS 
 Over a period of time, the chicken has proved to be an outstanding model for 
biomedical research, especially in the field of immunology which can be exemplified by 
the invention of attenuated vaccines, the discovery of B cells and interferon, the first 
successful vaccines against a cancer, and more (Burgess, 2004). With the recent 
publication of the chicken genome sequence and development of functional genomics 
complemented with proteomics and bioinformatics, biomedical research in chicken has 
gained a whole new dimension. However, biologically active peptides in chicken and 
related species are still under explored. The advancements in proteomic technologies and 
bioinformatics also increase the likelihood of the identification, sequencing, and 
biological characterization of novel peptides that are hitherto unknown. Identification of 
endogenous bioactive peptides would not only be valuable for therapeutic purposes but 
also would help in improving poultry production, health, and welfare. For example, 
antimicrobial peptides can be useful for protection against pathogens, increasing food 
safety. Thus, the future for prospecting endogenous bioactive peptides is bright. 
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ABSTRACT 
      The aim of the study was to determine chicken monocyte- and granulocyte- 
associated peptides and proteins using “whole cell” matrix assisted laser 
desorption/ionization time-of-flight mass spectrometry and to characterize the peptides 
based on their abundance. The mass spectra showed a prominent peak at m/z 4963 in 
monocytes/macrophages but not in the granulocytes. Subsequent purification and 
characterization of the m/z 4963 peptide from an avian macrophage cell line HTC, 
revealed it to be thymosin β4 (Tβ4), an actin modulating peptide. HTC cells when treated 
with bacterial lipopolysaccharide and peptidoglycan to determine the modulation of Tβ4 
gene expression or its secretion, showed no changes. 
Key words: chicken macrophage thymosin beta 4, mass spectrometry  
 
INTRODUCTION 
      Mononuclear phagocytes and granulocytes are two major effectors of innate 
immunity that defend against microbes, mediate inflammatory response, and contribute to 
the tissue repair process. Despite an overlap of their functions that are mediated through 
many common cytokines, growth factors, and signal transduction agents, it is likely that 
these cells produce an abundance of different signatory proteins and peptides that may be 
of importance to their function and physiology. Thus, we have been interested in 
identifying protein and peptide profiles of these cells based on their occurrence and 
relative abundance. Mass spectrometry has emerged as a formidable tool not only to 
characterize biomolecules but has also been used to identify different prokaryotic cells by 
virtue of their molecular profiles. Matrix assisted laser desorption ionization/time of 
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flight mass spectrometry (MALDI-TOF MS) has been used for this purpose [1, 2]. 
However, the potential of this technique to study the molecular profiles of eukaryotic 
cells has not been much explored. To determine the applicability of this technique to 
differentiate between cell types we performed “whole cell MALDI” [2] on mononuclear 
cells and granulocytes of chicken peripheral blood. This report deals with the 
identification of thymosin beta 4 (Tβ4) as an abundant peptide present in avian 
monocytes/macrophages and its regulation by bacterial lipopolysaccharides (LPS) and 
peptidoglycans (PGN) which modify macrophage functions.   
 
MATERIALS AND METHODS 
Whole cell MALDI of mononuclear cells, granulocytes, and macrophages 
      All animal procedures followed Institutional Animal Care and Use Committee 
guidelines. Potassium-EDTA anti-coagulated blood was collected from 3 week-old 
broiler chickens by cardiac puncture and subjected to density gradient centrifugation on a 
PolymorphoprepTM medium (Accurate Chemical Company, Westbury, NY) to isolate 
both mononuclear cells and granulocytes as described earlier for avian blood[3]. After 
two successive washings and centrifugation, the cell pellets were resuspended in RPMI 
1640, to a concentration of 1x106 cells/ ml.  Two μl of each cell suspension was mixed 
with an equal volume of one molar 2,5-dihydroxybenzoic acid (DHB) in 90% methanol 
containing 0.1% formic acid and spotted onto a Bruker MTP 384 stainless steel MALDI 
target. MALDI-TOF MS analysis was performed in the mass range of 1-20 kDa using a 
Bruker Reflex III MALDI-TOF mass spectrometer (Bruker Daltonik GMBH, Bremen, 
Germany) in positive ion mode. Spectral distributions and relative intensities were the 
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primary criteria of selecting peaks for further investigation. Using the mononuclear cell 
MALDI spectrum as reference we compared it with two avian macrophage cell lines 
HTC [4] and HD11 [5]. All these cells gave a prominent peak at m/z 4963. Subsequent 
experiments including the purification and the characterization of the peptide responsible 
for the peak at m/z 4963 and its regulation was performed using the HTC macrophage 
cells grown in culture. 
 
Reverse phase HPLC Purification and ESI Mass Spectrometry 
      HTC cells were extracted with 70% ethanol containing 0.2% acetic acid at 
concentrations of 1×107 cells/ml and centrifuged at 21,000×g for 10 min to obtain the 
supernatant. The supernatant was dried using a SpeedVac concentrator (Savant 
Instruments, Inc., Farmingdale, NY) and reconstituted to one tenth of its original volume 
with distilled water. It was then subjected to reverse phase high pressure liquid 
chromatography (RP-HPLC) using a Hewlett Packard (Palo Alto, CA) 1100 series HPLC 
instrument and monitored using a single wavelength UV detector and a Bruker Esquire 
2000 quadrapole ion trap electrospray ionization mass spectrometer (ESI MS) (Billerica, 
MA).  A Bio wide Pore C8 reverse phase column (4.6 mm × 15 cm, 5 µm) (Supelco, St. 
Louis, MO) was used with a solvent flow rate of 0.7 ml/min using a 0.1% formic 
acid/acetonitrile gradient of 0-50% over 40 min.  The ESI MS was operated in positive 
ion mode with the nebulizing pressure (N2) at 2.1×105 Pa (30 Psi), and a drying gas 
temperature at 300ºC with flow of 12 ml/min. The mass spectrometer was optimized at 
m/z 1000 with low skimmer voltage. After optimizing the HPLC separation by 
monitoring the effluent simultaneously at 214 nm and by ESI MS, appropriate fractions 
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with m/z 4963 were collected, pooled, and evaporated to dryness. This fraction was tested 
by MALDI TOF MS to confirm the presence and the purity of the compound.  
 
Peptide mass fingerprinting 
      The HPLC fraction obtained corresponding to m/z 4963 was dissolved in 25 mM 
ammonium bicarbonate solution and an aliquot was subjected to trypsin digestion at 37°C 
for 22 h using sequencing grade recombinant trypsin (Promega, WI). The trypsin digest 
was then desalted and concentrated using Ziptip C18 pipette tips (Millipore, Bedford, 
MA) according to the manufacturers suggested procedure. Two μl of the eluted sample 
was mixed with an equal volume of saturated α-cyano-4-hydroxycinnamic acid in 34% 
acetonitrile containing 0.1% formic acid, spotted onto a stainless steel MALDI target, and 
analyzed by MALDI-TOF MS as described above. The peptide mass fingerprint was 
subjected to a NCBI data base search for identification using the MASCOT search engine 
(http://www.matrixscience.com). The search was performed using a compiled list of the 
30 most abundant monoisotopic peaks in the mass spectrum of the tryptic digest. 
 
Effects of immunomodulators on Tβ4 gene expression 
      Two immunostimulatory agents, Salmonella typhimurium lipopolysaccharide (LPS) 
and Streptococcal pyrogenes peptidoglycan (PGN-PS) (Becton Dickinson, Franklin 
Lakes, NJ) were used to activate HTC cells and determine their effects on Tβ4 gene 
expression and its secretion into the culture medium. HTC cells were grown in RPMI-
1640 medium containing 10% fetal bovine serum for 12 h at a concentration of 2×106 
cells/ml/well in 24 well cell culture plates. Duplicate cultures were then treated with 
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either phosphate buffered saline (PBS) (control) or 1 μg LPS or 10 μg PG-PS in PBS for 
an additional 12 h. At the end of incubation, the cells were centrifuged at 250×g and the 
supernatant was used to determine Tβ4 concentration by a competitive enzyme 
immunoassay using a rabbit anti-human Tβ4 antiserum (Abcam, Cambridge, MA) and 
human Tβ4 (ProSpec-Tany TechnoGene Ltd, Israel) as the coating antigen and the 
standard [6, 7]. The nitrite and the IL-6 concentrations in the culture supernatant was 
determined using Griess reagent [8] and a B9 hybridoma bioassay[9] as described earlier 
[3, 4]. 
      After removing the medium, the cells were washed once with sterile PBS and DNA 
free total cellular RNA was purified using RNAeasy and On-column DNA digestion kits 
(Qiagen Corp, Chatsworth, CA). RNA was reverse transcribed to cDNA using a 
Retroscript kit (Ambion, Austin, TX). Two microgram RNA equivalent of cDNA was 
amplified using a “hot start” Taq Polymerase Multiplex PCR kit (Qiagen Corp, 
Chatsworth, CA) in a 200 gradient Peltier Thermal Cycler (MJ Research, Watertown, 
MA, USA) for 30 cycles. The conditions included denaturation at 94°C for 1 min, 
annealing at 60°C for 30 sec, and extension at 72°C for 1 min using primers for Tβ4, 
interleukin-6 (IL-6), and inducible nitric oxide synthase (iNOS) along with β-actin as the 
reference gene [10]. The primers were designed with the Primer 3 software program [11] 
from the coding sequences of chicken Tβ4 (Genbank Accession # NM_001001315) [12], 
IL-6 (Genbank accession # AJ309540) [13], and iNOS (Genbank accession # U46504  
[14, 15]. The primer sequences for Tβ4: forward: 5’GCCGAGATCGAGAAATTTGA3’; 
reverse: 5’GAAGGCAATGCTTGTGGAAT 3’. The coding sequences of chicken IL-6 
precursor and iNOS were, forward: 5’CTCCTCGCCAATCTGAAGTC3’; reverse: 
 34 
5’TCATAGAGACGCTGCTGCCAG3’; forward: 5’AGGCCAAACATCCTGGAGGTC3’; reverse 
5’TCATAGAGACGCTGCTGCCAG3’ respectively. The PCR products were analyzed by 2% 
agarose gel electrophoresis using a low range DNA ladder as standard (Fermentas, 
Hanover, MD). The gels were stained using ethidium bromide and photographed. The 
expression of genes for IL-6 and iNOS, along with the accumulation of IL-6 and nitrite in 
the conditioned media were used as positive controls as the indicators of macrophage 
activation. 
 
RESULTS 
Whole cell MALDI of mononuclear cells, granulocytes, and macrophages 
      The whole cell MALDI TOF mass spectra of mononuclear cells and the HTC cells 
are shown in Figs. 1 and 2. There were several small peaks associated with the 
mononuclear cell population along with a prominent peak at m/z 4963. The macrophage 
cell lines HTC and HD11 showed profiles similar to mononuclear cells with a prominent 
spectral peak at m/z 4963 (Fig. 2). The granulocytes, on the other hand, showed a 
prominent peak corresponding to m/z 3915 but not 4963 (data not shown). 
 
Reverse phase HPLC Purification of 4963 Da peptide 
      The reverse phase-HPLC chromatogram of acid-alcohol extract of HTC cells is 
shown in Fig. 3a.  Based on the analysis of HPLC fraction, a peptide corresponding to 
m/z 4963 was observed to elute at about 10.8 min. The HPLC/ESI-MS spectrum of this 
peptide is shown in Fig 3b. The peaks at m/z 829, 994, 1242 and 1655 correspond to the 
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+6, +5, +4 and +3 charged peptide ions, respectively (Fig. 3b). An oxidized form of the 
peptide with m/z 4979 was a minor peak in the chromatogram. 
 
Peptide mass fingerprinting 
      Attempts to determine the N-terminal sequence of the peptide with m/z 4963 by 
Edman degradation failed, suggesting that it may be N-terminally blocked. MASCOT 
database searches using the 30 most abundant monoisotopic tryptic fragments along with 
a single set of search parameters (4 missed cleavages, 100 ppm mass error, and N-
terminus variable acetyl modification in the protein level) resulted in a statistically 
significant hit corresponding to Tβ4 in Gallus gallus. The search also indicated that Tβ4 
contains methionine at the 6th position that can be oxidized to thymosin β4 sulfoxide, 
which accounts for the peak observed at m/z 4979 (Fig. 2).  
 
Expression of Tβ4 gene 
      The agarose gel electrophoresis profile of PCR products showed no change in the 
expression of Tβ4 in response to either LPS or PGN-PS. However, an increased 
expression of both IL-6 and iNOS genes were evident (Fig. 4). Enzyme immunoassay 
showed no detectable levels of Tβ4 in the culture medium of either control or treated 
cells but the concentrations of IL-6 and nitrite increased by both LPS and PGN treatments 
(Table 1). The absence of any significant peak corresponding to Tβ4 was also confirmed 
by MALDI-TOF MS using the Ziptip purified culture supernatant (data not shown). 
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DISCUSSION AND CONCLUSION 
     The foregoing results demonstrate that whole cell MALDI-TOF has the potential to 
provide insight into cellular characteristics and their possible functions based on the 
relative abundance of their signatory proteins and peptides. The results show that the 
peptide corresponding to m/z 4963 is indeed thymosin β4, an evolutionarily conserved 
peptide that regulates actins polymerization [16, 17]. Its presence in chicken tissues was 
shown using hybridization of a rat Tβ4 probe with chicken blood DNA [18]. However, 
the complete structure of the chicken peptide was not known until 2004 when Dathe and 
Brand-Saberi [12] predicted its sequence from the Tβ4 EST nucleotide sequence. The 
reported peptide sequence did not suggest N-terminal modification and it also contained 
an additional lysine at the C terminus [12] resulting in an average mass of 5181 Da. 
However, our results show that the chicken Tβ4 has a molecular mass of 4963 Da, 
identical to that of human peptide [19, 20]. While, the N-terminal peptide modification 
may not be apparent from nucleotide sequences, the presence of a C-terminal lysine in 
the chicken sequence remains puzzling. 
     The relative abundance of Tβ4 in macrophages and the tissues rich in 
macrophages and lymphocytes such as the spleen, bone marrow, and lungs, [18, 21, 22] 
suggests that it may possibly have other physiological significance aside from its G-actin 
sequestering property. It has been shown that monocyte/macrophages produce Tβ4, and 
suggested that its oxidized form, thymosin β4 sulfoxide, has better anti-inflammatory 
efficacy compared with Tβ4 itself [23]. Whereas intracellular up-regulation of Tβ4 has 
been linked to cancerous and metastatic transformation of cells [24, 25] it has also been 
shown to promote angiogenesis, wound healing, mediate tissue remodeling, subvert 
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inflammation, and prevent apoptosis when administered extracellularly [26-29]. Other 
lines of evidence are suggestive of Tβ4 having anti-microbial activity against several 
gram positive and gram negative bacteria [30]. These extra cellular actions of Tβ4 are 
consistent with the functions of macrophages that not only have antimicrobial activities 
but are also involved in the resolution of inflammation by promoting tissue healing and 
angiogenesis [31]. A high level of occurrence of Tβ4 in macrophages is likely to help 
these functions. However, the secretion of Tβ4 has been controversial due to an apparent 
absence of a signal sequence [18, 32].  Several studies have shown the occurrence of Tβ4 
in wound fluids, [33] suggesting that it can not only be secreted but also actively 
internalized. To examine whether activation of macrophages results in Tβ4 secretion and 
alters the expression of its gene, the HTC cells were treated with bacterial LPS and 
peptidoglycan. Although these treatments changed the expression of genes encoding IL-6 
and iNOS along with their corresponding products, IL-6 and nitrite, there was neither any 
effect in the expression of Tβ4 mRNA nor its concentration in the condition medium. 
Thus, it is likely that the Tβ4 in the wound fluids may be derived from dying or dead 
cells or is secreted under different conditions and by other cell types as has been 
demonstrated by Bock-Marquette et al [34]. Dead macrophages and similar other cells 
such as the platelets, in the inflamed areas, may also provide Tβ4 to initiate extracellular 
functions such as wound healing. In conclusion, although the physiological significance 
of Tβ4 in macrophages is speculated, the mechanism and conditions under which it is 
expressed and regulated need to be determined. 
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Table 1: Effects of lipopolysaccharide (LPS) and peptidoglycan on nitrite, IL-6, and Tβ4  
concentrations of HTC cell culture supernatant. 
 
Treatment Nitrite  
µg/ml 
Interleukin-6 
Units/ml 
Thymosin β4 
PBS (Control) 0.14 ± 0.06 0.03 ± 0.003 BD 
LPS (1µg/ml) 1.66 ± 0.03 1.752 ± 0.02 BD 
PG-PS (10µg/ml) 1.48 ± 0.03 1.618 ± 0.04 BD 
BD= below detection 
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FIGURE LEGENDS 
Figure 1:  Whole cell MALDI-TOF mass spectrum of chicken peripheral blood 
mononuclear cells isolated by density gradient separation showing m/z 4963 as a major 
peak. 
Figure 2:  Whole cell MALDI-TOF mass spectrum of HTC cells showing m/z 4963 as a 
major peak. 
Figure 3: (a) RP-HPLC trace of HTC cell extract showing the elution of 4963 Da and 
4979 Da peptides. (b) Electrospray mass spectrum from the HPLC fraction collected at 
10.8 min. 
Figure 4: An agarose gel electrophoresis profile of RT-PCR amplicons of Tβ4, IL-6, 
iNOS, and β-actin from HTC cells treated with either control medium (1), 1 μg LPS (2), 
or 10 μg PG-PS (3) for 12 h.  
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ABSTRACT 
Matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-
TOF-MS) was used to screen avian heterophils in the m/z range of 1-20 kDa with an 
objective to identify the cell associated peptides that may be reflective of their functional 
physiology.  The MALDI-TOF-MS profiles of crude heterophil extract showed a high 
intensity peak with average mass of m/z 3916.1 for chicken and at m/z 4129.6 for turkey 
respectively. To identify these peaks, we first purified m/z 3916.1 from chicken bone 
marrow extract using reverse phase high performance liquid chromatography (RP-
HPLC). Edman sequencing and peptide mass fingerprinting exclusively confirmed this 
peptide as beta-defensin 2 (BD2) or gallinacin-2, a broad range antimicrobial peptide. 
Uniprot database search followed by the MASCOT sequence query revealed m/z 4129.6 
to be the corresponding turkey ortholog of avian beta-defensin 2 (AvBD2), also called 
turkey heterophil peptide 2 (THP2). Both AvBD2 peptides are 36 amino acids long 
including a highly conserved region with 6 invariant cysteines forming three disulfide 
bonds characteristic of defensins.  These results demonstrate that screening of the crude 
extract by MALDI-TOF-MS can identify cell or tissue associated peptides in their 
functional/mature forms. This study also confirms the existence and the complete mature 
peptide sequence of the turkey heterophilic BD2 previously proposed based on cDNA 
analysis. 
Key words: heterophils, mass spectrometry, avian beta defensin 
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INTRODUCTION 
Low molecular weight (MW) proteins (<20 kDa) and peptides regulate many 
physiological functions as hormones, neurotransmitters, antimicrobials, growth and 
signaling factors. It is likely that differentiated cells and tissues express many bioactive 
peptides, which can serve as biomarkers. Identifying and characterizing these peptides in 
cells and tissues can provide insight into their functional physiology involving 
development, differentiation, metabolism, and disease related changes.  Although there 
has been a rapid development in peptide research over the last few decades, 
“peptidomics” is still under explored because small peptides are not well suited for 
resolution by conventional proteomic techniques such as 2D gel electrophoresis 
(McNulty and Slemmon, 2004). However, recent advances in mass spectrometry (MS) 
particularly MALDI and ESI techniques have facilitated direct screening, identification 
and characterization of small peptides with significant sensitivity and accuracy (Schwartz 
et al., 2003). MS techniques have been applied at the organismal levels to characterize 
prokaryotes (Fox, 2006; Lay, 2001), to study physiological and pathological changes at 
tissue levels (Blomqvist et al., 1999; Chaurand et al., 1999; Nelsestuen et al., 2005), and 
to characterize biological fluids and cellular secretions (Hida et al., 2005; Li et al., 2000; 
Romanova et al., 2006; Schrader and Schulz-Knappe, 2001; Thompson et al., 2006; 
Williams et al., 2006). MS based identification and characterization of tissue associated 
peptides has been extensively used to study neuropeptides from a variety of organisms 
(DeKeyser and Li, 2007; Desiderio et al., 2000; Schmidt et al., 2008). Using a whole cell 
screen, we have previously detected differential profiles of peptides in monocytes and 
granulocytes and identified thymosin beta4 in chicken monocytes and macrophages 
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(Kannan et al., 2007; Rath et al., 2007). However, characterizing such peptides and 
understanding their relevance to specific cell physiologies or use as biomarkers requires 
extensive study. Also, the homology of peptides and peptide biomarkers between related 
species needs more study.  To explore the detection of biomarker peptides in discrete 
cells and related species, we screened the crude heterophil extracts of chickens and 
turkeys by MALDI-TOF-MS. Based on the signal intensities in the spectra from crude 
extracts we selected 2 peptides (one from each species) for further study.  More complete 
characterization of these potential biomarkers was accomplished by HPLC/MS and 
Edman degradation to establish their identities.  In this case both peptides were identified 
as AvBD2 from each species.  It is noteworthy that the specific AvBD2s reported herein 
have been confirmed in chicken and from cDNA studies in turkey (Brockus et al., 1998; 
Evans et al., 1994; Harwig et al., 1994).  This report provides experimental evidence in 
complete agreement with the prior studies on chicken and turkey BD2.   
 
MATERIALS AND METHODS 
Chemicals 
One Step PolymorphTM medium (Accurate Chemicals Co, Westbury, NY), recombinant 
trypsin (Promega, Madison, WI), RPMI-1640 medium (Mediatech Inc., Herndon, VA), 
C18 ZipTip micropipette tips (Millipore, Bedford, MA), and K-EDTA Vacutainer tubes 
(BD Bioscience, Franklin, NJ) were purchased from the respective companies.  All other 
chemicals and reagents were obtained from Sigma Chemical Company (St. Louis, MO). 
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Isolation of Heterophils 
All animal procedures were approved by institutional animal use and care committee. 
Blood was obtained from three week-old broiler chickens and six week-old turkeys by 
cardiac puncture using K-EDTA Vacutainer tubes prior to killing.  Three ml of individual 
blood samples were layered over 2ml PolymorphprepTM density gradient medium and 
spun at 500 X g for 40 min at 23°C. The density gradient medium containing 
granulocytes, between the top mononuclear cell layer and the bottom red blood cells, was 
treated per manufacturer’s protocol to isolate granulocytic heterophils as described 
previously (Rath et al., 1998). The granulocyte preparations from chickens and turkeys 
were pooled separately, centrifuged to pellet the cells, washed 3 times with RPMI-1640 
medium by successive centrifugation at 380 X g for 8 min each.  The purity of cells was 
determined by staining the cytocentrifuged cells with fluorescein isothiocyanate (FITC) 
and propidium iodide (PI) (Rath et al., 1998) which showed the cells to be predominantly 
heterophil granulocytes (Fig 1). 
 
Chicken and Turkey Bone marrow Preparation 
The birds were killed by carbon dioxide inhalation and the tibias were removed free of 
soft tissues and periosteum.  The tips of each extremity was cut and the bones were 
placed in 15 ml centrifuge tubes and spun at 100 X g for 5 min at 23°C to collect the 
bone marrow.  The bone marrows were frozen at -200C until extraction. 
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MALDI-TOF-MS 
The heterophil granulocytes (1x106cells/ml) and the bone marrow (~100 mg/ml) were 
extracted with 70% methanol containing 0.2% acetic acid for 2 h to overnight, and 
centrifuged at 21,000 X g for 10 min to obtain the supernatant.  Two μl of supernatant 
was mixed with an equal volume of 1M 2, 5-dihydroxybenzoic acid (DHB) in 90% 
methanol containing 0.1% formic acid and spotted onto a Bruker MTP 384 stainless steel 
MALDI target.  MALDI-TOF-MS analysis was performed in the spectral range of m/z 1-
20 kDa in positive ion reflectron mode using a Bruker Reflex III MALDI-TOF mass 
spectrometer (Bruker Daltonik GMBH, Bremen, Germany). Reproducibility and signal 
intensity were the primary criteria for the selection of corresponding peaks to purify and 
characterize the peptides. Average mass values were measured in the MALDI-TOF-MS 
experiments on crude extracts.  
 
Reverse Phase HPLC-ESI-MS  
The chicken bone marrow extract was subjected to RP-HPLC (Hewlett 1100; Hewlett 
Packard, Palo Alto, CA) separation using SUPELCO C8 column (15 cm x 4.6 mm, 5 µm) 
which is coupled online to a quadrapole ion trap electrospray ionization mass 
spectrometer (ESI-MS) (Bruker Esquire 2000; Billerica, MA) for MS analysis.  The 
chicken peptide m/z 3916.1 was purified at a solvent flow rate of 0.7 ml /min using a 
0.1% formic acid/ acetonitrile gradient of 0-50% over 50 min period. The ESI-MS was 
operated in positive ion mode with the dry gas temperature of 300ºC, drying gas flow of 
12 ml/min and nebulizing N2 pressure of 2.1 × 105 Pa (30 Psi). The mass spectrometer 
was optimized at m/z 1000 with low skimmer voltage to avoid ion fragmentation and 
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charge stripping. After optimizing the HPLC separation by monitoring the effluent 
simultaneously using total ion chromatogram and by ESI-MS, the fractions 
corresponding to m/z 3916.1 was collected, pooled, and evaporated to dryness using a 
SpeedVac concentrator (Savant Instruments, Inc., Farmingdale, NY). Homogeneities of 
these fractions were tested by MALDI-TOF-MS to confirm the purity of the peptides.  
 
Automated Protein Sequencing 
The RP-HPLC purified m/z 3916.1 peptide was spotted on a PVDF membrane and 
subjected to an automated Edman degradation using an Applied Biosystems Procise 
sequencer (Weiterstadt, Germany) to determine the N-terminal sequence.  
 
Peptide mass Fingerprinting using MALDI-TOF-MS 
Replicate aliquots of the purified peptide of average mass m/z 3916.1 were reconstituted 
in 25 mM ammonium bicarbonate and subjected to reduction and alkylation prior to 
digestion with recombinant trypsin.  Peptide aliquots were reduced for 1 hr with 10 mM 
1,4- dithiothreitol (DTT) followed by alkylation with 20 mM 2-iodoacetamide in dark for 
25 min at 37°C.  Excess iodoacetamide was quenched by an addition of DTT.  Reduced 
and alkylated peptides were then digested with trypsin for 22 h at 37°C, desalted, and 
concentrated using C18 ZipTips as recommended by manufacturer’s protocol. Two μl of 
the eluted sample was then mixed with an equal volume of saturated α-cyano-4-
hydroxycinnamic acid prepared in 34% acetonitrile containing 0.1% formic acid and 
spotted on to the MALDI target plate for MS analysis. A Bruker reflex III MALDI-TOF 
mass spectrometer was operated in positive ion reflectron mode and optimized in the m/z 
 55 
range of 500 Da to 2 kDa.  Peptide mass finger print obtained from the MALDI-TOF-MS 
was subjected to data base search as described below.  Monoisotopic mass values were 
measured and used in the peptide mapping experiments. 
 
Database Search for m/z 3916.1 
Using the partial N- terminal sequence of m/z 3916.1, a NCBI blast search 
(http://www.ncbi.nlm.nih.gov) and a MASCOT sequence query search 
(http://www.matrixscience.com) were done to establish this peptide’s identity. The tryptic 
peptide mass fingerprint (PMF) MASCOT search confirmed the identification of the 
peptide. The PMF was performed using a compiled list of 10 most abundant 
monoisotopic peaks in the mass spectrum. PMF search parameters at NCBInr database 
were set to a peptide tolerance of 100 ppm with fixed carbamidomethyl modification and 
maximum number of missed cleavages set to one under chordate taxonomy.  
 
Sequence Query for m/z 4129.6 
Based on the chicken sequence, the Uniprot database in the Expasy proteomic server 
(http://www.expasy.org/uniprot/P46158) was used to test for homologous sequences, in 
this case to determine the identity of the turkey peptide. It was verified by Mascot 
sequence query search using the reduced average mass 4135.7 (+6 Da for disulfides) and 
partial Edman sequence of the chicken peptide.  
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RESULTS 
 MALDI-TOF-MS Profiles 
Table 1 shows a list of twelve most abundant peaks from the MALDI-TOF-MS spectra of 
chicken and turkey heterophils. Fig. 2 and 3 show the MS profiles of methanol-acetic 
acid extract of chicken and turkey bone marrow.  The most intense peaks in the chicken 
and turkey bone marrow spectra were found at m/z 3916.1 and m/z 4129.6 respectively 
similar to their corresponding peaks observed in the MALDI-TOF-MS profile of the 
heterophils (Fig. 2 and 3, Table 1).  
 
Reverse Phase HPLC Purification of m/z 3916.1 peptide 
The total ion chromatogram (TIC) of methanol-acetic acid extract of the chicken bone 
marrow is shown in Fig. 4. The peptide corresponding to m/z 3916.1 was eluted at about 
24.2 min. Corresponding ESI-MS spectrum of the peak, shown in Fig. 5, confirms the 
occurrence of the peptide in its four multiple-protonated species, m/z 650.9, 784.3, 979.9, 
and 1305.9, with charges corresponding to +6, +5, +4, and +3 respectively (Fig 5). 
 
Edman Sequencing 
Edman degradation of m/z 3916 yielded an N-terminal partial sequence of first 15 amino 
acids: LF_KGGS_HFGG_PS. The missing amino acid positions in between are 
conventionally assigned to be unmodified cysteine residues. 
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Identification of m/z 3916.1 peptide 
NCBInr blast search with the partial sequence LFCKGGSCHFGGCPS produced 
alignments with Gallus gallus beta-defensins 2, 3 and 1. However, the BD2 sequences 
showed the highest hit with an expected value (E) of 2e-08 compared with BD 3 and 1 
that had an E value of 36. The E value refers to the number of matches with equal or 
better scores that are expected to occur by chance alone. MASCOT sequence query was 
done using the reduced monoisotopic peptide mass 3919.6 along with the partial N-
terminal sequence LFCKGGSCHFGGCPS. The search parameters at Swissprot/NCBInr 
database set at peptide tolerance 100 ppm and maximum number of missed cleavages at 
zero under taxonomy of chordate resulted in a statistically significant hit for Gallus 
gallus BD2. 
          Identification of 3916 peptide was further established by its tryptic mass fingerprint 
generated by MALDI-TOF-MS (Fig 6). MASCOT data base search using the tryptic 
mass fingerprint also resulted in a statistically significant hit for AvBD2 with a high 
probability MOWSE score of 112 and an E value of 5.9e-06. The peaks from the peptide 
mass fingerprint, m/z 929.4, 1208.5, 1613.7, 2161.9 (Fig 6), corresponded to the cysteine 
modified tryptic peptides, VGSCFGFR (position 20-27), SCCKWPWNA (position 28-
36), GGSCHFGGCPSHLIK (position 5-19), LFCKGGSCHFGGCPSHLIK (position 1-
19) respectively thus, showing a sequence coverage of 100% spanning the mature Gallus 
gallus AvBD2 peptide sequence. 
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Identification of m/z 4129.6 peptide 
The first attempt to identify this peptide was a homology search.  The Uniprot database 
search for chicken AvBD2 homologous peptides identified turkey heterophil peptide 2 
with 90% homology.  Likewise a MASCOT sequence query using its reduced average 
mass and partial chicken AvBD2 sequence also resulted in a hit for THP2 with a high 
probability MOWSE score of 235 and an E value of 3e-18.   Because cDNA experiments 
have also predicted the same sequence for turkey AvBD2 (Brockus et al., 1998), it was 
evident that this peptide (THP2) was indeed with MW 4129.6.  Since the peptide was 
identified as a homolog, additional experiments were not needed. 
 
DISCUSSION 
The study was initiated with the hypothesis that different cells may exhibit their specific 
profiles of peptides in a manner reflective of their physiology, and also that it might be 
possible to extrapolate across taxonomy.  MALDI-TOF-MS analysis of crude extracts of 
chicken and turkey heterophils showed different spectral profiles for each population of 
cells. Using signal intensity as a criterion we selected two high intensity peaks, m/z 
3916.1 in chicken and m/z 4129.6 in turkey, to determine their identities.  The first was 
clearly established as chicken AvBD2 and the second was consistent with a known turkey 
protein, THP2, that was predicted to be AvBD2, an ortholog of chicken AvBD2 or 
gallinacin-2  (Brockus et al., 1998; Evans et al., 1994; Harwig et al., 1994).  AvBD2 is a 
cationic anti microbial peptide predominantly expressed in heterophils, intestinal and 
reproductive tissues of the birds (Harwig et al., 1994; Hida et al., 2005; van Dijk et al., 
2007; Yoshimura et al., 2006).  Since heterophils originate in the bone marrow, it appears 
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to be a significant source of this peptide. Other than chicken and turkey, AvBD2 
orthologs have been found in other species of birds such as penguins, ostriches, and 
pigeons (Sugiarto and Yu, 2006; Thouzeau et al., 2003; van Dijk et al., 2008).  The beta-
defensins, in general, have a wide spectrum anti-microbial activity and exhibit 
evolutionarily high conservancy such as the position specific disulfide bonds (Brogden, 
2005; Sugiarto and Yu, 2004; Zasloff, 2002). In chickens approximately 14 different 
AvBD has been identified (Lynn et al., 2007).  The identification of different chicken 
AvBDs in their pre-protein forms have been made by genome browsing and 
bioinformatics followed by gene expression studies (Higgs et al., 2005; Lynn et al., 2004; 
Xiao et al., 2004). Since the exact processing of pro peptide is not understood, the 
identity of mature peptides that have been deduced by bioinformatics approaches have 
led to varying masses of the mature form. For example the mature peptide for chicken 
AvBD2 has been reported to have different masses (Harwig et al., 1994; Higgs et al., 
2005; Lynn et al., 2004; Xiao et al., 2004).   In our study, the molecular mass of the 
mature chicken AvBD2 showed to be 3916.1 consistent with the results of Harwig et al. 
(1994) and the turkey peptide 4129.6 as reported (Evans et al., 1994). A second peptide 
with m/z 4503 present in the chicken heterophils and bone marrow extracts, also shows to 
be an exact match with beta-defensin 1 reported by Harwig et al (1994).  
        In a previous study we compared peripheral blood heterophils, mononuclear cells, 
and a chicken macrophage line HTC and identified the presence of thymosin b4 in 
chicken macrophages but not in the granulocytes (Kannan et al., 2007; Rath et al., 2007). 
Both AvBD1 (m/z 4503) and AvBD2 were absent in the macrophages. Although both 
macrophages and heterophils are derived from the bone marrow and share many over 
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lapping innate immune functions, they show distinctive spectral profiles by MALDI-
TOF-MS suggesting that these profiles might be tissue or cell specific. While genome 
based bioinformatics has the advantage of predicting the structure of the whole peptide or 
proteins, the MALDI based approach can be a tool of discovery and identification of 
known as well as novel peptides possibly in their functional/mature forms. In this 
application MALDI-TOF-MS may be a rapid method to probe cell or tissues for 
physiological changes, and perhaps disease associated changes.  A potential downside of 
direct MALDI approach is that in a typical mixture of peptides, all molecules do not 
ionize with equal efficiency because of the differences in amino acid composition and 
some sequences are suppressed by co-occurring peptides.  This problem can be easily 
corrected by peptide fractionation using standard chromatographic approaches before 
MALDI.  However, at this point this limitation is largely theoretical, because most related 
peptides will have similar spectral behavior. Moreover, the time/cost advantages of the 
direct analysis of cells or crude extracts suggest that this should be the method of first 
resort.  In conclusion, our study shows that rapid screening of crude extracts by MALDI-
TOF-MS can detect important homologous peptides relevant to disease or other 
peptidomics endpoints, even across species lines. 
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Table 1: Average mass and relative intensities of the twelve most abundant peaks 
associated with the MALDI-TOF of a typical crude chicken and turkey heterophil extract. 
The errors for the given masses are ± 100 ppm. 
 
Chicken Heterophils Turkey Heterophils 
Peaks (m/z) Relative Intensities Peaks (m/z) Relative Intensities 
3916.1 1 4129.6 1 
3844.9 0.70 2784.1 0.91 
3731.2 0.53 4362.5 0.24 
2811.2 0.36 5516.1 0.12 
4503.9 0.27 8565.0 0.12 
2601.6 0.18 5091.1 0.09 
5353.4 0.12 2588.2 0.09 
3531.2 0.10 2065.2 0.08 
8165.7 0.09 5939.5 0.06 
13959.9 0.09 6026.1 0.05 
7646.8 0.07 6598.1 0.05 
6027.1 0.05 9685.5 0.03 
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FIGURE LEGENDS 
Figure 1: Chicken peripheral blood heterophils stained with FITC and propidium iodide 
(X400 magnification) 
Figure 2: MALDI-TOF-MS of chicken bone marrow extract shows m/z 3916 (arrow) as 
a high intensity peak. 
Figure 3: MALDI-TOF-MS of turkey bone marrow extract showing several peaks along 
with m/z 4129.1 (arrow) as the most prominent peak. 
Figure 4: Total ion chromatogram of RP-HPLC of chicken bone marrow extract showing 
the elution of 3916 Da peptide at 24.2 min.  
Figure 5: Electrospray ionization mass spectrum of the HPLC fraction collected at 24.2 
min showing different protonated species of 3916 Da peptide 
Figure 6: Peptide mass fingerprint of m/z 3916 after trypsin digestion. Arrows 
correspond to MW of tryptic peptides spanning different stretches of amino acids with 
carbamidomethyl (CAM) modification of the cysteine residues in the positions specified 
in the parenthesis. 
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Figure 3. 
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Figure 4. 
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Figure 5. 
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Figure 6. 
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ABSTRACT 
Defensins are antimicrobial peptides containing six cysteine residues bridged internally 
by 3 characteristic disulfide bonds. Only beta defensin isoforms occur in birds. Avian 
beta defensin 2 (AvBD2) is the major isoform present in heterophils. In this study, we are 
reporting a direct MALDI approach to screen and identify avian beta defensins from 
crude heterophil and bone marrow extracts leading to the deduction of amino acid 
sequences for pheasant and quail AvBD2. Taking advantage of the characteristic three-
disulfide bonds in defensins by reduction and alkylation, using dithiothreitol and 
iodoacetamide, this approach was able to differentiate these peptides from others with 
different numbers of disulfide bonds.  Before reduction/alkylation, MALDI-TOF mass 
spectra of heterophil extracts of chicken, turkey, pheasant, and quail showed high 
intensity peaks corresponding to m/z 3916, 4129, 4114, and 4163 respectively, but after 
reduction/alkylation, these peaks were shifted by 348 Da consistent with the presence of 
six cysteine residues. Metastable ion decay studies of corresponding reduced/alkylated 
ions by MALDI LIFT-TOF/TOF showed the presence of a conserved stretch of 4 amino 
acids, ‘LFCK’ at the N-terminal, indicative of AvBD2. Comparing with known 
sequences of chicken and turkey AvBD2, the pheasant and quail peptide sequences were 
deduced assuming 90% homology. MALDI in source decay (ISD) fragmentation was 
performed for the respective peptides, purified by reverse phase HPLC from their bone 
marrow extracts. This was a parallel approach to verify the sequence obtained from direct 
MALDI by MS/MS (MALDI LIFT-TOF/TOF) which showed the sequences to be 
congruent. 
Key words: avian beta defensin, mass spectrometry, tandem mass spectrometry, MALDI 
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Introduction 
Defensins are cationic, cysteine-rich antimicrobial peptides that are one of the 
most evolutionarily conserved components of innate immunity occurring in many 
vertebrate and invertebrate species. 1-5 The interaction between positive charges on 
defensins and negatively charged sites on microbial membranes forms the basis of their 
antimicrobial effects against a broad range of bacteria, fungi, protozoa and enveloped 
viruses. 2, 6, 7 Vertebrate defensins are classified into three main categories, namely α, β 
and θ defensins, based on disulfide bond pairing of 6 conserved cysteine residues as 
Cys1-Cys6, Cys2-Cys4, Cys3-Cys5 for α defensins, Cys1-Cys5, Cys2-Cys4, Cys3-Cys6 
for β defensins and Cys1-Cys4, Cys2-Cys5, Cys3-Cys6 for θ defensins. 4, 8-10 The 
absence of α and θ defensins in sub mammalian vertebrates, such as birds and fish, 
suggests that defensin subfamilies possibly evolved from an ancestral β defensin gene by 
duplication, polymorphism, and diversification. 11 The major sources of these defensins 
are myeloid cells such as neutrophils (heterophils in birds) and epithelial cells. 8, 12-15 
While over 14 isoforms of beta defensins have been identified in various chicken 
tissues only a few have been reported from other species of birds. 16-19 The functional and 
mature forms of these peptides are the result of signal and other tissue specific 
peptidases. Although genomics and bioinformatics have facilitated prediction of defensin 
structures, they cannot unambiguously predict the functional and mature forms of the 
peptide therefore, requiring experimental verifications. In recent years, mass 
spectrometry has been successfully applied to identify and characterize many cell and 
tissue associated peptides in several invertebrate and vertebrate species. 20, 21, 22 This 
strategy can reveal tissue associated mature and functional peptides, sometimes even with 
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minimal pre-analysis sample preparation. In previous studies, using direct screening of 
chicken and turkey heterophil extracts, by MALDI-TOF-MS followed by HPLC 
purification, we identified β defensins respectively in their mature forms, which on 
reduction and alkylation showed a 348 Da mass shift. 23, 24 Hence, the current study was 
undertaken to extend our prior work to identify AvBD2 from two other avian species, 
pheasant and quail, using a rapid and a simple approach to increase the specificity with 
minimal impact on the method’s sensitivity. Reduction and alkylation was incorporated 
to our general MALDI approach to selectively screen peptides having 6 cysteine residues 
followed by mass spectrometric fragmentation to sequence these peptides. This ‘top 
down’ fragmentation was introduced in place of a relatively time consuming ‘bottom up’ 
enzymatic digestion method which involves HPLC isolation and MALDI peptide mass 
fingerprinting (PMF). Herein, we report for the first time the mature peptide sequence of 
pheasant and quail AvBD2. 
 
Experimental Procedures 
Chemicals and Reagents. One Step PolymorphTM gradient (Accurate Chemicals 
Co, Westbury, NY), K-EDTA Vacutainer tubes (BD Bioscience, Franklin, NJ), C18 
ZipTip micropipette tips (Millipore, Billerica, MA), Bio-Rad dye binding reagent  (Bio-
Rad, Hercules, CA), peptide calibration standards (m/z 500-5000 Da, Bruker Daltonics, 
Bremen, Germany), Bio wide Pore C8 reverse phase HPLC column (15 cm x 4.6 mm, 5 
µm) (Supelco, St. Louis, MO) were purchased from respective vendors. All other 
reagents including fluorescein isothiocyanate (FITC), propidium iodide (PI), 1,4- 
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dithiothreitol (DTT), 2-iodoacetamide (IAA), 2, 5-dihydroxybenzoic acid (DHB), 1,5-
diaminonaphthalene (DAN) were purchased from Sigma Aldrich (St. Louis, MO). 
 
Isolation of Heterophils. Heterophil granulocytes were isolated from K-EDTA 
anti-coagulated peripheral blood using One Step PolymorphTM gradient centrifugation. 23 
The cells were washed with RPMI media successively and the granulocyte enrichment 
was determined for purity by staining the cells with FITC and PI. 25 Following bleeding, 
birds were euthanized and bone marrow collected from tibia as described previously. 23 
Bone marrow samples were frozen at -200C until extraction.  
 
Sample Preparation and Direct MALDI Screening. Approximately, 1x106 
heterophils or ~100 mg of bone marrow from chicken, turkey, pheasant and quail were 
homogenized in 1 mL of 70% methanol containing 0.2% acetic acid, allowed to 
precipitate overnight at 40C, and centrifuged at 21,000 X g for 10 min to obtain the 
supernatant. For preliminary screening, the crude supernatants were mixed in equal 
volumes with 1M DHB prepared in 90% methanol, 0.1% formic acid. Spotting was done 
using the standard dried droplet method by allowing 1-2 microlitres of a 1:1 
matrix/analyte mixture to air dry on a Bruker MTP 384 ground stainless steel MALDI 
target. Mass spectra were acquired on Reflex III MALDI-TOF (Bruker Daltonics GMBH, 
Bremen, Germany) operated in the positive-ion reflectron mode. Carbamidomethylation 
was performed by reducing the extracts for 1 hr with 10 mM 1,4-dithiothreitol (DTT) 
followed by alkylation with 20 mM 2-iodoacetamide in the dark for 25 min at 370C. 24  
High intensity mass spectral peaks showing the expected carbamidomethylation of six 
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cysteines, as indicated by a 348 Da mass shift (after alkylation), were tentatively 
identified as beta defensins and subjected to subsequent MS based sequencing. 
 
MALDI-MS Sequencing. Presumed beta defensins were sequenced using two 
different MS approaches. Main approach proposed here for quick and direct analysis 
involved metastable parent ion selection followed by LIFT-TOF/TOF to study fragment 
ions produced by its gas phase unimolecular dissociation 26. The other method used for 
verification utilizes an indirect approach involving HPLC purification followed by matrix 
enhanced MALDI-ISD fragmentation.  These experiments were performed on an 
Ultraflex II MALDI TOF/TOF (Bruker Daltonics GMBH, Bremen, Germany). The 
amino acid sequence was derived from differences between the selected parent ion’s 
mass and the masses of the metastable ion fragments in the MS/MS spectrum. For ISD 
studies, peptides were first purified by reverse phase HPLC chromatography (Hewlett 
1100; Hewlett Packard, Palo Alto, CA) from their respective bone marrow extracts using 
a method described previously. 23 The HPLC fractions corresponding to these peptides 
were collected and tested for purity by MALDI-TOF-MS before and after subjecting to 
reduction and alkylation. The experiments relying on enhanced ISD employed a saturated 
solution of DAN prepared in 50% ACN/ 0.1% FA as the matrix. 27, 28 The purified and 
reduced/alkylated peptides were each mixed with DAN in equal volumes and spotted on 
the MALDI target plate.  Then the MALDI-ISD mass spectra were used to verify the 
sequence derived from the metastable ion decay studies.  
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Data Analysis. Chicken and turkey AvBD2 peptide sequences 13, 29 were used as 
references to determine the sequences of the pheasant and quail peptides. Bruker Flex 
Analysis 2.4, 3.0 softwares were used to generate the peak list from the MS/MS and MS 
spectra.  For MS/MS the average isotopic mass values were used whereas for MS with 
enhanced ISD the monoisotopic mass values were used for sequence determining 
calculations.  Typically a, b and y ions were observed in metastable ion decay studies by 
MALDI LIFT-TOF/TOF (MS/MS) whereas c and z+2 ions dominated the matrix-
enhanced ISD experiments.  Spectra generated from reduced/alkylated forms of chicken 
and turkey AvBD2 were compared with their corresponding theoretical fragment ions 
using Bruker’s Biotools 3.1 software.  Ions generated from the reduced/alkylated 
pheasant and quail peptides were likewise compared with those of chicken and turkey 
AvBD2 to identify differences indicative of possible mutations in their amino acid 
sequences.  
 
Results and Discussion 
Screening Beta Defensin like Peptides by Direct MALDI. Direct screening of 
tissue extracts by MALDI-TOF-MS has been shown to be a promising strategy not only 
to identify and characterize novel peptides but also to distinguish cell specific proteins 
and peptides. 30-34 Direct MALDI-TOF-MS of crude heterophil extracts from chicken, 
turkey, pheasant and quail, showed distinct spectral profiles attributable to their 
individual peptide constituents (Figure 1). Not surprisingly, bone marrow extracts from 
all four species also contained peaks similar to those present in the corresponding 
heterophil MALDI-TOF-MS profiles (data not shown). The most prominent and distinct 
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peaks were m/z 3916 in chicken, m/z 4129 in turkey, m/z 4114 in pheasant and m/z 4163 
in quail. The chicken m/z 3916 and turkey m/z 4129 corresponded to their mature AvBD2 
peptides having four amino acid differences but otherwise more than 90% sequence 
homology. 13, 23, 29 By analogy, high intensity peaks from pheasant and quail heterophil 
extracts obtained under similar conditions, could likely represent respective beta 
defensins. A simple way to provide additional evidence regarding the identity of the 
peptides in these samples was selective alkylation of cysteine residues. Direct MALDI-
TOF mass spectral profiles obtained for reduced/alkylated heterophil extracts of each 
species showed that the specific peptide peaks were shifted by 348 Da upon 
carbamidomethylation indicative of six cysteines, characteristic of beta defensins.  
Figures 2a and b compare direct MALDI-TOF-MS profiles of chicken before and after 
reduction/alkylation. The most intense peak at m/z 3916 (AvBD2) and the peak at m/z 
4503, which corresponds to chicken AvBD1, were shifted by 348 Da. In turkey, the 
intense peak at m/z 4129 identified as AvBD2 23 also shifted by 348 Da (Figure 2c,d) 
whereas peak at m/z 2784 did not show a mass shift suggesting that it has no cysteine 
residues. The Figures 2e,f for pheasant and 2g,h for quail, illustrate shifts of two 
respective high intensity peaks by 348 Da. By analogy with chicken and turkey AvBD2, 
it was likely that the reduced/alkylated peaks at m/z 4463 and 4512 correspond to 
pheasant and quail AvBD2 respectively. 
 
Identification of Avian Beta Defensin 2.  The ions at m/z 4264, 4478, 4463 and 
4512 from chicken, turkey, pheasant and quail respectively, were examined by MS/MS 
(MALDI LIFT-TOF/TOF) to obtain sequence information. Fragment masses from 
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chicken and turkey were compared with pheasant and quail to identify similarities and 
differences for the conserved or mutated regions in the amino acid sequences.  The 
observed fragment ions in Table 1, for chicken and turkey AvBD2 were consistent with 
the known sequences of these species.  
A systematic approach was used to compare certain common ions of pheasant and 
quail with those of chicken and turkey starting with N- and/or C- termini fragments (an, 
bn and yn series).  For instance, fragment ions at m/z 550 and 522 were found common in 
all four species (Table 1). Therefore, based on the chicken and turkey sequences and 
conservancy with other avian species 12, 13, 18, 19, 35, 36 these b4 and a4 ions correspond to 
the N-terminal amino acid stretch of LFCK (position 1-4), a characteristic of AvBD2 
(Figure 3).  Table 1 shows a series of ions in pheasant identical to yn in chicken up to 
n=24 which indicates that the amino acid stretch from position 13 to 36 in pheasant are 
same as in chicken corresponding to sequence ‘CPSHLIVGSCFGFRSCCKWPWNA’. The 
observed accurate intact monoisotopic mass difference between chicken and pheasant 
peptide showed 198 Da (chicken, m/z 3913.7 and pheasant, m/z 4111.8). Since the amino 
acid sequences in pheasant peptide of 1-4 and 13-36 of pheasant are the same as chicken 
AvBD2, the 198 Da mass differences could be nested in the N-terminal stretch of amino 
acids between 5 and 12 due to specific positional mutations. Because, the amino acids at 
position 6 and 8-11 are reported to be highly conserved in AvBD2, across species such as 
chicken, turkey, duck, and ostrich, (Figure 3), the most likely mutations in pheasant 
would be at positions 5, 7 or 12. Replacing glycine (G) at position 5 and 12 in chicken 
AvBD2 with arginine (R) matched the mass difference of 198 Da between chicken and 
pheasant peptides leading to a possible sequence of 
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‘LFCKRGSCHFGRCPSHLIKVGSCFGFRSCCKWPWNA’ which was in agreement with other 
observed an and bn ions (Table 1). 
Likewise, a series of fragment ions similar to yn in chicken were found in quail up 
to y24, all of which were shifted by a constant mass of 49 Da (Table 1).  For instance, 
peak at m/z 253 in quail was 49 Da higher than the y2 ion of chicken. The peak at m/z 
3118 of quail was 49 Da more than the y24 of chicken. This is coherent with possible 
mutation of asparagine (N) to tyrosine (Y) at position 35 in quail.  The fact that the same 
series of ions, mentioned above, showed 48 Da differences compared with yn series up to 
y24 in turkey, further supports the possible mutation of aspartic acid (D) to tyrosine (Y) 
transition at position 35 in quail (Table 1).  As noted above, the amino acid sequence of 
1-4, 6 and 8-11 are reported to be highly conserved in AvBD2 across the species. 
Therefore, mutations are most likely present at positions 5, 7 or 12.  Replacing serine (S) 
at position 7 and glycine (G) at position 12 of chicken AvBD2 with glutamic acid (E) and 
asparagine (N) respectively, matched the exact mass of the quail peptide (m/z 4160.7) 
leading to a possible sequence of ‘LFCKRGECHFGNCPSHLIKVGSCFGFRSCCKWPWYA’. 
This was further in agreement with other observed fragment ions an and bn (Table 1). 
The most probable mutations consistent with the data and the corresponding 
sequences for pheasant and quail peptides are given in Figure 4. The annotations in 
Figure 5 and masses listed in table 1 represent some of the observed and calculated 
fragment ions of chicken, turkey, and the proposed pheasant, and quail AvBD2 
sequences.  
Sequences predicted by MALDI LIFT-TOF/TOF were evaluated by MALDI-ISD 
fragmentation enhanced by DAN as a matrix. While matrix selection and other 
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approaches can be used to enhance the low level of ISD inherent in MALDI mass spectra, 
associating any fragment with a specific parent ion remains difficult.  Therefore, the 
peptides were purified by HPLC and their purity was verified using MALDI-TOF-MS 
with DHB prior to enhancement of ISD using the DAN matrix.  The use of ISD 
fragments in MALDI mass spectra as a means of sequencing is a ‘top down’ approach 
similar to metastable ion decay analysis by MALDI LIFT-TOF/TOF. The MALDI-ISD 
and MALDI LIFT-TOF/TOF data are complementary to one another and both provide 
better sequence information than a typical ‘bottom up’ enzymatic digestion method as 
evident from Figures 5, 6 and Table 1, 2.  Although reduced/alkylated ISD fragments are 
used for sequencing, this approach can also be used without reduction and alkylation 
(Figure 7). It is customary to do reduction/alkylation to yield better fragmentation and 
sequence specific information for peptides containing disulfide bonds. 27, 28  As seen in 
Figure 6 and Table 2 (reduced/alkylated pheasant peptide) and Figure 7 and Table 2 (non 
reduced pheasant peptide), the ISD fragmentation appears to be more extensive after 
alkylation than before.  However, in both these cases, most of the observed cn and z+2n 
ISD fragment ions covered a wider range of the overall sequence.  While ISD data 
presented herein, are based on the proposed sequence (Figure 4), the observations made 
with cn and z+2n ions also suggests the possibility to derive the sequences directly and 
independently (Table 2, Figure 6 and 7). For example, cn series ions from n=8-12 and 14-
28, and z + 2n series ions from n=10- 22 were observed for reduced/alkylated form of 
pheasant peptide based on the sequence obtained from MALDI LIFT-TOF/TOF, (Figure 
6, Table 2). This observation not only supports the proposed N-terminus sequence, 1-28, 
and the C-terminus sequence, 14-36 (Table 2), but also confirms the presence of amino 
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acid sequence tags that correspond to ‘HFGR’,  ‘SHLIKVGSCFGF’ and  
‘FGFCSGVKILHS’ (Figure 6). Similar observations were made for MALDI-ISD mass 
spectra obtained from non reduced pheasant peptide which showed cn series ions n=8-25, 
27, 28 and z+2n series ions n=10-21 and 25-28. This supports the N-terminus sequence 1-
28 and C-terminus sequence 8-36 (Table 2), and proves the existence of stretches of 
amino acids corresponding to ‘HFGRCPSHLIKVGSCFGF’, ‘FGFCSGVKILH’, and 
‘GFH’ (Figure 7).  Quail ISD data showed cn series ions from n=8-17, z+2n series ion 
from n=19-27 for reduced/alkylated form supporting N-terminus sequence 1-17 and C-
terminus sequence 9-36, obtained by the MALDI LIFT-TOF/TOF. Similarly, the ISD 
data obtained for non-reduced quail peptide showed cn series ions n= 8-16 and 22-26, and 
z+2n series ion n=10-14, 21, 22, and 25-28 further supporting N-terminus sequence 1-26 
and C-terminus sequence 8-36 (Table 2). The combined information from ISD data 
obtained from non reduced and reduced/alkylated quail peptide confirms ‘HFGNCPSHL’ 
and ‘CFGF’ sequence tags. It should be noted that complementary information was 
obtained from both the fragmentation methods. Typical bn and yn ions observed in 
metastable ion decay studies by MALDI LIFT-TOF/TOF were derived from CO-NH 
bond cleavage whereas cn and z+2n ions observed in ISD fragmentation were produced by 
NH-CH bond cleavage. Besides, MALDI LIFT-TOF/TOF method depends primarily on 
the mass selection of the parent ion, whereas the ISD requires pre MS purification that 
gives better fragmentation.  
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Conclusion 
In conclusion we report the identity of two new avian AvBD2 orthologs in 
pheasant and quail for the first time.  The AvBD2 sequences determined are: 
‘LFCKRGSCHFGRCPSHLIKVGSCFGFRSCCKWPWNA’ and 
‘LFCKRGECHFGNCPSHLIKVGSCFGFRSCCKWPWYA’, for pheasant and quail respectively. 
This study demonstrates a direct MALDI approach to identify beta defensin like peptides 
in complex mixtures without any elaborate separation processes such as the 1D/2D gel 
electrophoresis, multidimensional HPLC chromatography, or enzymatic/ chemical 
digestion processes.  Identification is based on the finding of 6 cysteine residues by 
cysteine-specific alkylation followed by the determination of the amino acid sequences 
by MALDI LIFT-TOF/TOF.  ISD fragmentation using DAN as the MALDI matrix 
verified the sequences obtained from MALDI LIFT-TOF/TOF data. 
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Table 1. MS/MS fragmentation ions obtained by MALDI LIFT-TOF/TOF showing 
theoretical and observed masses of selective an, bn and yn ions of the reduced/alkylated 
chicken, turkey, pheasant and quail peptides.  
 
 
Ion types 
Chicken Turkey Pheasant Quail 
Theo Obsv Theo Obsv Theo Obsv Theo Obsv 
a4 521.7 520.5 521.7 520.8 521.7 520.2 521.7 522.7 
a6 635.8 N/D 734.9 735.1 734.9 735.1 734.9 734.7 
a8 883.1 N/D 996.2 998.6 982.2 982.5 1024.2 1025.6 
a10 1167.4 1168.4 1280.5 1281.5 1266.5 1267.2 1308.6 1308.9 
a15 1625.9 1626.3 1838.2 1837.8 1824.1 1823.1 1824.1 1825.3 
a16 1763.0 1763.5 1975.3 1975.7 1961.3 1962.7 1961.2 1960.1 
a18 1989.3 1989.9 2201.6 2202.3 2187.6 2188.4 2187.6 2186.3 
a26 2872.4 2873.6 3084.7 3084.6 3070.6 3071.4 3070.6 3070.2 
a35 4147.8 N/D 4361.1 N/D 4346.1 4344.1 4395.1 4394.1 
b1 114.2 113.6 114.2 113.27 114.2 113.3 114.2 114.1 
b2 261.3 260.9 261.3 260.99 261.3 261.2 261.3 260.6 
b3 421.5 422.4 421.5 N/D 421.5 421.6 421.5 421.0 
b4 549.7 549.0 549.7 549.0 549.7 549.3 549.7 550.9 
b7 750.9 N/D 864.0 N/D 850.0 850.2 892.1 892.6 
b8 911.1 911.8 1024.2 N/D 1010.2 1010.9 1052.3 1053.6 
b9 1048.2 1048.9 1161.4 1162.0 1147.4 1147.5 1189.4 1188.7 
b10 1195.4 1196.2 1308.6 N/D 1294.5 1294.5 1336.6 1337.0 
b11 1252.4 1253.5 1365.6 1366.5 1351.6 1352.5 1393.6 1394.4 
b12 1309.5 1309.7 1521.8 1522.9 1507.8 1508.5 1507.7 1508.1 
b14 1566.8 N/D 1779.1 1781.0 1765.1 1767 1765.0 1765.0 
b15 1653.9 N/D 1866.2 1864.3 1852.2 1853 1852.1 1853.2 
b18 2017.3 N/D 2229.6 2230.6 2215.6 2217 2215.6 2215.4 
b20 2244.6 N/D 2456.9 2456.9 2442.9 2443 2442.9 2242.2 
b36 4246.9 4247.9 4460.2 4460.6 4445.2 4446.5 4494.2 4493.6 
y1 90.1 N/D 90.1 N/D 90.1 90.5 90.1 89.0 
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y2 204.2 204.4 205.2 204.3 204.2 204.3 253.3 253.3 
y4 487.5 487.9 488.5 488.9 487.5 487.9 536.6 538.3 
y7 962.1 N/D 963.1 963.1 962.1 964.3 1011.2 1009.5 
y13 1717.0 1717.4 1718.0 1718.6 1717.0 1717.9 1766.0 1765.2 
y14 1877.2 1877.6 1878.1 1878.2 1877.2 1877.3 1926.2 1925.1 
y15 1964.2 1964.6 1965.2 N/D 1964.2 1962.7 2013.3 2012.0 
y16 2021.3 2021.6 2022.3 2022.0 2021.3 2021.7 2070.4 2071.2 
y18 2248.6 2248.7 2249.6 2247.5 2248.6 2249.1 2297.7 2299.4 
y21 2612.1 2612.5 2613.0 N/D 2612.1 2612.9 2661.1 2660.8 
y23 2796.2 2796.8 2797.2 2797.9 2796.2 2796.8 2845.3 2845.3 
y24 2956.4 2957.0 2957.4 2958.1 2956.4 2956.9 3005.5 3005.1 
y25 3013.5 3014.5 3113.6 3114.1 3112.6 3113.7 3119.6 3118.9 
y26 3070.5 3071.8 3170.7 3171.5 3169.7 3170.6 3176.7 3176.0 
y27 3217.7 3218.9 3317.8 3318.6 3316.9 3318.4 3323.8 3324.7 
y28 3354.9 3355.8 3455.0 3456.1 3454.0 3455.3 3461.0 3461.6 
y29 3515.1 3516.2 3615.2 3616.3 3614.2 3614.8 3621.2 3621.4 
y33 3844.4 3845.0 4057.7 N/D 4042.7 4042.3 4091.7 4091 
y36 4264.9 4264.9 4478.2 4477.8 4463.2 4463.4 4512.2 4511.2 
Theo= theoretical; Obsv= observed; N/D= not detected 
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Table 2.  Fragmentation ions obtained by MALDI ISD showing theoretical and observed 
masses of selective cn and z+2n ions of pheasant and quail AvBD2 before and after 
reduction/alkylation.  
 
Ion types 
Reduced/alkylated Non reduced 
Pheasant Quail Pheasant Quail 
Theo Obsv Theo Obsv Theo Obsv Theo Obsv 
c8 1026.5 1026.4 1068.5 1068.5 912.5 912.6 954.5 954.7 
c9 1163.6 1163.5 1205.6 1205.6 1049.5 1049.7 1091.5 1091.8 
c10 1310.6 1310.6 1352.6 1352.7 1196.6 1196.8 1238.6 1239.0 
c11 1367.6 1367.7 1409.7 1409.7 1253.6 1253.8 1295.6 1296.0 
c12 1523.7 1523.8 1523.7 1523.7 1409.7 1409.9 1409.7 1410.2 
c14 1780.8 1780.8 1780.8 1780.8 1609.8 1610.0 1609.7 1610.2 
c15 1867.9 1867.9 1867.8 1867.9 1696.8 1697.0 1696.8 1697.3 
c16 2004.9 2004.9 2004.9 2003.8 1833.9 1834.1 1833.8 1833.3 
c17 2118.0 2118.0 2118.0 2118.0 1946.9 1947.2 1946.9 N/D 
c22 2602.3 2602.2 2602.3 N/D 2431.2 2431.6 2450.2 2450.6 
c23 2762.3 2762.2 2762.3 N/D 2534.3 2534.7 2553.2 2553.5 
c24 2909.4 2909.3 2909.4 N/D 2681.3 2681.8 2700.2 2700.5 
c25 2966.4 2966.3 2966.4 N/D 2738.3 2738.8 2757.3 2757.4 
c26 3113.5 3113.3 3113.4 N/D 2885.4 N/D 2904.3 2904.5 
z+2(10) 1349.6 1349.6 1398.6 N/D 1235.5 1235.7 1265.5 1264.9 
z+2(11) 1496.7 1496.7 1545.7 N/D 1382.6 1382.8 1412.6 1412.2 
z+2(12) 1553.7 1553.7 1602.7 N/D 1439.6 1439.9 1469.6 1469.1 
z+2(13) 1700.7 1700.8 1749.8 N/D 1586.7 1586.9 1616.7 1616.2 
z+2(21) 2595.2 2595.2 2644.2 2644.2 2424.2 2424.5 2473.1 2473.5 
z+2(22) 2682.3 2682.2 2731.3 2731.2 2511.2 N/D 2560.1 2559.4 
z+2(25) 3095.4 3095.3 3102.4 3102.3 2867.4 2867.7 2874.2 2874.4 
z+2(26) 3152.5 N/D 3159.4 3158.3 2924.4 2923.9 2931.3 2931.3 
z+2(27) 3299.5 3299.3 3306.5 3307.3 3071.4 3071.3 3078.3 3078.2 
z+2(28) 3436.6 N/D 3443.5 N/D 3208.5 3209.7 3215.4 3215.1 
Theo= theoretical; Obsv= observed; N/D= not detected 
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FIGURE LEGENDS 
Figure 1. MALDI-TOF mass spectra of crude heterophil extracts of chicken, turkey, 
pheasant and quail. 
Figure 2. MALDI-TOF mass spectra of non-reduced and reduced/alkylated heterophil 
extracts of chicken (a and b), turkey (c and d), pheasant (e and f), and quail  
(g and h). Arrows indicate the intact and modified forms of AvBD. 
Figure 3. Mature AvBD2 peptide sequences of chicken, turkey, duck and ostrich aligned 
with respect to their conserved regions. 
Figure 4. Proposed sequences of mature AvBD2 of pheasant and quail aligned with 
chicken and turkey counterparts. The highlighted amino acids are the proposed 
mutations. 
Figure 5. MALDI LIFT-TOF/TOF MS/MS spectra of (a) chicken, (b) turkey, (c) 
pheasant and (d) quail showing an, bn and yn ion fragments. 
Figure 6. MALDI MS ISD fragmentation profile of purified and alkylated pheasant 
AvBD2, showing cn and z+2n ions.  
Figure 7. MALDI MS ISD fragmentation profile of purified and non-alkylated pheasant 
AvBD2, showing cn and z+2n ions.  
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Figure 5. 
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ABSTRACT 
Thymosin beta 4 (Tβ4) is a 5 kDa actin sequestering intracellular peptide which has been 
shown to possess a variety of extracellular functions including chemotaxis, wound 
healing, tissue remodeling, and angiogenesis. However, the regulation of Tβ4 production 
and the mechanism of its secretion to extracellular environment are not understood.  
Previously, we found that the chicken macrophage is a rich source of Tβ4. Since 
macrophages play a central role in innate immunity including their participation in wound 
healing and angiogenesis, the objective of this study was to find whether activation of 
macrophages through appropriate toll-like receptors (TLR) would promote Tβ4 synthesis 
and secretion. We treated chicken macrophages with different TLR agonists and studied 
their effects on cellular and extracellular Tβ4 levels  at 6 and 24 h time points. Real time 
PCR was used to determine changes in gene expression while SILAC followed by mass 
spectrometry was used to monitor Tβ4 content in cells and conditioned media. The results 
show that while certain TLR activators, induced the expression of reference genes 
(interleukins-1β, -6, and nitric oxide synthase) indicative of macrophage activation, none 
caused any significant change on Tβ4 gene activation. The SILAC data however, showed 
a decrease in the cellular Tβ4 content along with its corresponding detection in cell 
culture supernatants at 24 h by PGN, PAM and LPS. No changes in Tβ4 level were 
detectable at 6 h time point. In the absence of any change in Tβ4 gene expression that 
would indicate its intracellular replenishment, the decrease in cellular Tβ4 levels at 24 h 
could likely relate to macrophage death induced by those agonists.  Using lactate 
dehydrogenase (LDH) activity of the conditioned media, as an indicator of cell death, our 
results show that those agonists which showed depletion of cellular Tβ4 also caused 
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higher LDH levels in the conditioned media. These results imply that Tβ4 in the 
extracellular fluid likely originate from dying cells. 
Keywords: macrophage, SILAC, thymosin beta 4, toll-like receptor 
 
INTRODUCTION 
Thymosin beta 4 (Tβ4) is a highly conserved polypeptide, originally identified as T cell 
maturation factor in the thymus gland and later found to occur ubiquitously in many cells 
and tissues [1, 2]. Tβ4 binds to the cytoplasmic G-actin preventing its polymerization to 
F-actin thus, regulating cytoskeletal organization, and cell motility [3, 4]. Extracellularly, 
Tβ4 promotes a variety of functions including chemotaxis, angiogenesis, wound healing, 
and down regulate inflammation [5-8]. Additionally, Tβ4 also possesses antimicrobial 
activity, facilitates antigen presentation, and is one of the major genes up regulated 
following immune activation [9, 10].  Although many of its diverse effects on different 
cells and tissues have been understood using exogenous Tβ4, the mechanism of its 
synthesis and secretion to extracellular environment is not well understood [7, 11].  
In the course of screening for bioactive peptides in phagocytic cells, we identified 
Tβ4 as an abundantly occurring peptide in chicken macrophages [12]. The macrophages 
are a major component of innate immunity, which participate in many functions 
attributed to Tβ4 such as, wound healing, angiogenesis, and tissue remodeling [13-15]. 
The macrophages recognize various microbial pathogens and their products through a 
series of ‘pattern recognition receptors (PRR)’ called toll-like receptors (TLR) [16] that 
cause their activation leading to the synthesis and secretion of various cytokines, 
chemokines, metabolites, and enzymes which in turn mediate different biological effects 
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[13, 17]. Therefore, the objective of this study was to find whether TLR activation would 
lead to the production of Tβ4 by the macrophages, which could then participate in post-
inflammatory healing processes.  
 
MATERIALS & METHODS 
Reagents and chemicals 
Dialyzed fetal bovine serum (FBS) and SILAC RPMI-1640 cell culture media (L-
arginine and L-lysine depleted) were purchased from Pierce (Rockford, IL).  13C1 labeled 
lysine (H) was obtained from Cambridge Isotope Laboratories (Andover, MA).  BCA 
protein assay kit (Pierce, Rockford, IL), RNAeasy mini and on-column DNA digestion 
kit (Qiagen Corp, Chatsworth, CA), Retroscript reverse transcriptase kit (Ambion, 
Austin, TX), Multiplex PCR kit (Qiagen, Valencia, CA), SYBR green PCR master mix 
(Applied Biosystems, Austin, TX), and lactate dehydrogenase  (LDH) cytotoxicity kit 
(Promega, Madison, WI) were all purchased from the respective vendors. All other 
chemicals including L-lysine (L), L-arginine, non-enzymatic cell dissociation medium, 
antibiotic antimycotic solution, were obtained from Sigma-Aldrich (St. Louis, MO).  
 
Toll-like Receptor ligands 
The peptidoglycan-polysaccharide polymers PG-PS 10S (PGN), a sonicated cell wall 
preparation of Streptococcus pyrogenes, was a gift from BD Bioscience (San Jose, CA).  
The concentration of the product, 5mg equivalent rhamnose/ml 0.85% saline, was used to 
dilute to required concentration.  A synthetic lipoprotein Pam3CSK4 (palmitoyl- 3-
cysteine-serine-lysine-4; PAM), Salmonella typhimurium flagellin (FGN) and guanine 
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analog loxoribine (LOX) were purchased from Invivogen (San Diego, CA).  The CpG-
oligodeoxynucleotide (CpG-ODN 2006), corresponding to the sequence 
TCGTCGTTTTGTCGTTTTGTCGTT [18] was synthesized by Invitrogen (Carlsbad, 
CA). Salmonella typhimurium lipopolysaccharide (LPS) and dsRNA analog, polyI:C 
were purchased from Sigma-Aldrich (St. Louis, MO).  All the above ligands were 
prepared as stock solutions in sterile physiological water. 
 
Preparation of SILAC media 
L-Lysine (L) and L-arginine were dissolved in sterile PBS at a stock concentration of 
10g/L and 50g/L, respectively and filtered using a 0.2µm filter. A stock concentration 
(10g/L) of 13C1-lysine (H) was similarly prepared and filtered. The “Light (L)” SILAC 
medium for the control cells was prepared adding 2 mL of stock solution of L-arginine 
and 4 mL of lysine (L) to 500 ml of depleted RPMI 1640 medium. The “Heavy (H)” 
SILAC medium was prepared in a similar manner by adding 2mL of arginine and 4 mL 
of 13C1-lysine (H) stock solutions to 500 ml of depleted RPMI 1640 medium.  Both ‘L’ 
and ‘H’ SILAC media were filtered and supplemented with 10% dialyzed FBS, 20 mM 
glutamine, and 1X concentration of antibiotic antimycotic solution.  
 
Macrophage culture and activation by TLR agonists for SILAC studies 
Transformed chicken macrophage cell line HTC [19] cultured in RPMI-1640 media 
containing 10% FBS and 1X concentration of antibiotic antimycotic solution were 
initially grown in normal RPMI 1640 medium.  At 80% confluence, the media was 
aspirated and the cells were washed with PBS and detached using a non-enzymatic 
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dissociation medium for 5 min, and washed with PBS three times by successive 
centrifugation at 380 X g for 8 min each [12]. One half of the detached cells were seeded 
into the ‘L’ SILAC RPMI medium and the other half into the ‘H’ SILAC RPMI medium, 
prepared as described above. Metabolic labeling of cells were done according to Ong and 
Mann (2006) with 6 successive passages of cells in respective media that theoretically 
labels the entire proteome of the cells with 90-100 % efficiency [20]. Both light and the 
heavy isotope labeled HTC cells were detached and plated in triplicates at a concentration 
of 1 X 106 cells / ml in 12 well culture plates in their respective media and grown 
overnight incubated at 37ºC under 5% CO2. The H labeled cultures was then stimulated 
with different TLR agonists for 6 and 24 h.  Each TLR agonist treatment consisted of a 
triplicate culture consisting of: TLR2, gram positive bacterial peptidoglycan (PGN), 
TLR3, poly inosinic, cytidylic (poly I:C), TLR4,gram negative LPS, TLR5, flagellin, 
TLR2/1, PAM3CSK4, TLR7,Loxoribine; and TLR9, CpG-ODN [16].  The final 
concentrations of the agonists were PAM (1 µg/ml), PGN (1 µg rhamnose equivalent 
/ml), FGN (100 µg/ml), poly I:C (1 µg/ml), LOX (100 µM), CpG-ODN (5 µM) and LPS 
(1 µg/ml) respectively. The concentrations of the TLR agonists were based on values 
recommended by the suppliers and used in earlier literatures [21, 22].  
 
Sample preparation for MALDI-MS and SILAC studies 
After specified periods, 6 and 24 h of stimulation with TLR agonists, the plates were 
centrifuged at 300 X g for 10 min and the conditioned media from both control and 
treatment group were removed. Aliquots of the conditioned media free of cells were 
mixed with equal volumes of 100% methanol containing 2% acetic acid to denature and 
 113 
precipitate proteins over a 16 h period at 4°C, and centrifuged at 21,000 X g for 10 min to 
obtain the supernatant extract containing Tβ4. The adhered cells were washed with 
Dulbecco’s PBS twice, lysed with 200 µl of 0.1% n-octyl β-glucopyranoside (OβG  by 
repeated pipetting, and centrifuged at 21,000Xg for 10 min to obtain the cell lysate.  The 
cell lysate and conditioned media extract from each control (C) consisted of L and H 
lysine labeled samples (CL and CH) whereas the TLR agonist treated groups (T) consisted 
of only H lysine labeled samples (TH) based on the in vivo incorporation of stable 
isotopes (Fig.1).  Protein concentrations of both supernatant extract and cell lysates were 
determined using micro BCA protein assay to equalize the protein concentrations in case 
of variations between different samples. All the treatment samples (cell lysate and 
supernatant extract) were used individually but the L labeled control samples (cell lysate 
and supernatant extract) were pooled and used for all mixing experiments.  
 Cell lysate and supernatant extracts were mixed individually with an equal 
volume of one molar 2, 5-dihydroxybenzoic acid (DHB) in 90% methanol containing 0.1 
% formic acid and spotted onto a Bruker MTP 384 stainless steel MALDI target. 
MALDI-TOF spectra were acquired over the m/z range 1-10 kDa in the positive ion 
reflector mode using Bruker Reflex III MALDI-TOF mass spectrometer (Bruker Daltonik 
GMBH, Bremen, Germany) [12, 23]. The data were processed using Bruker Flex 
Analysis 2.4/3.0 software.  Initial screening of the supernatant extract and cell lysate 
samples of CL, CH and TH by MALDI-TOF-MS was done to detect the presence of Tβ4 
(m/z 4963, protonated molecule in CL and m/z 4972, protonated molecule in CH and TH).  
Following preliminary screening, pooled control CL and individual CH were mixed 1:1 to 
determine the intensity ratios of L and H Tβ4 in the cell lysate and conditioned media by 
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MALDI-TOF-MS as above.  Based on the peak intensities observed in the mass spectrum 
for L and H Tβ4, the intensity ratios (CH /CL) for controls and (TH /CL) were calculated 
for all treatment groups. The final fold changes or the relative changes in the levels of 
intracellular C and released Tβ4 were calculated by dividing the intensity ratio TH /CL 
over CH /CL. The mean and standard error of the mean (SEM) was calculated for control 
and each treatment group using measurements obtained from individual set of 
experiments repeated thee times. The results were evaluated using Students t-test and a p 
value ≤ 0.05 was considered significant.  
 
Activation of macrophages by TLR agonists for other analysis 
HTC cells of 1 X 106 / mL were seeded and grown separately in triplicates in normal 
RPMI 1640 medium and treated with different TLR agonists as above for 6 and 24 h for 
gene expression and other analyses.  For nitrite and LDH determination, the conditioned 
media was collected from all samples at both time periods, centrifuged, and saved at  -
200C until assay. 
 
Gene expression studies 
The macrophage activation induced changes in the expression of Tβ4 and other reference 
genes were assessed at 6 h stimulation as follows: Total RNA was extracted from control 
and TLR agonist treated macrophage cultures using RNAeasy Mini Kit. Any 
contaminating DNA was subjected to on column digestion with RNase-free DNase 1 
according to the manufacturer’s instructions. The cDNA was synthesized using 
Retroscript reverse Transcriptase kit.  The gene-specific primers for Tβ4, IL-6, IL-1β, 
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iNOS and β-actin were designed with the Primer 3 software program 
(http://frodo.wi.mit.edu/) (Table 1). The expression of genes for IL-6, IL-1β and iNOS 
were used as positive controls indicative of macrophage activation, and β-actin as the 
housekeeping gene. Q-PCR was used to determine the expression of target genes relative 
to the levels of the housekeeping gene β-actin.  Following optimization of primer 
concentrations and volumes (what does it mean?), real-time PCR was performed using an 
ABI Prism 7700 Sequence Detector (Applied Biosystems, Austin, TX). Each mRNA 
sequence was amplified in duplicate in 25 µL reactions containing SYBR green PCR 
master mix; cDNA corresponding to 1 µg of reverse transcribed RNA and 200 nM 
(optimized concentration) of forward and reverse primers. Both a no template and no 
reverse transcriptase control were included for each amplification reaction, and the 
homogeneity of the amplified products were confirmed routinely by melting curve 
analysis. The results were analyzed by the standard curve method and normalized to β-
actin as an endogenous control. Then the relative fold change in the expression of target 
genes (Tβ4, IL-6, Il-1β and iNOS) were assessed between the non stimulated control or 
TLR agonist stimulated macrophages. 
 
Nitrite and LDH measurement 
The nitrite content of all conditioned media was measured as described earlier using 
Griess reagent [19].  The LDH activity of the conditioned media was used as an indicator 
of cell damage or death [24]. The assays were done using control and treatment culture 
supernatants at both 6 and 24 h time points. The LDH activity was measured using a 
cytotoxicity assay kit according to the manufacturer’s protocol. 
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Statistics 
The quantitative results were evaluated using students t test.  A p value ≤ 0.05 was 
considered significant. 
 
RESULTS 
TLR activation induced Tβ4 release  
MALDI-MS profiles of 1:1 mixtures of ‘L’ control cell lysate and ‘H’ cell lysates and 
similarly treated conditioned media extracts are shown in Figs 2-4.  Protonated ion, m/z 
4963 corresponds to Tβ4 with ‘L’ lysine (12C) label, while m/z 4972 corresponds to Tβ4 
with ‘H’ lysine (13C).  Signal intensities of L and H Tβ4 were monitored at 6 h and 24 h 
time period. MALDI spectrum in Fig 2a shows L and H labeled Tβ4 in the 1:1 mixture of 
control cell lysates whereas Figs. 2b-h represent spectra from 1:1 mixture of control (L) 
and respective TLR agonist stimulated H cell lysates at 6 h. The signal intensity of L and 
H labeled Tβ4 remained approximately same in all groups in cell lysates at 6 h and in the 
corresponding conditioned media extract it was below the detection limit.  At 24 h time 
point, the cell-associated Tβ4 decreased significantly in PGN, PAM, and LPS treated 
cells (Fig 3). Both CpG and FGN treatments showed a moderate decrease but neither 
poly I:C nor LOX showed any change in cellular Tβ4 (Fig 3). Maximal decrease in the 
cellular Tβ4 was detected in PGN, PAM and LPS treated groups which was consistent 
with its presence in their respective conditioned media along with their oxidized forms 
(L: Tβ4 sulfoxide m/z 4979, H: m/z 4988; Fig 4).  It is note worthy that the oxidized form 
appeared to be the predominant form of the observed Tβ4 in the conditioned media (Fig 
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4). The relative changes in cellular Tβ4 in macrophages treated with different TLR 
agonists at 6 and 24 h are shown in Fig 5. Whereas at 6 h no change in cellular Tβ4 was 
observed, at 24 h PGN, PAM and LPS showed significant decrease in cellular Tβ4 (p ≤ 
0.001) along with CpG and FGN treated groups that also showed a lower albeit 
statistically significant decrease in cellular Tβ4 (p ≤ 0.05). 
 
Gene expression  
qPCR results for the mRNA expression in macrophage Tβ4, Il-6, Il-1β, iNOS relative to 
β-actin reference is shown in Fig 6. Tβ4 mRNA expression in both control and in all TLR 
agonist treatment groups remained unchanged. By contrast, PAM, PGN, LPS, CpG, and 
FGN induced a significant up-regulation of IL-1β, IL-6, and iNOS (Fig. 3) compared 
with the non-stimulated controls. However, FGN produced lesser effect on comparison 
with other agonists mentioned above. Both poly I:C and LOX agonists showed very 
minimal effect that was not statistically different from control. 
 
Functional activation of macrophages by TLR agonists 
Groups treated with TLR agonists PGN, LPS, PAM, FGN and CpG showed a moderate 
nitrite release at 6 h time point that was significantly enhanced at 24 h.  Except for poly 
I;C, and LOX all treatment groups a showed a significant increase in nitrite levels at 24h 
time points albeit some which showed very high levels of nitrite (Fig. 7).   
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LDH changes 
There were no differences in LDH activity between control and the different TLR agonist 
treated culture media at 6 h time point but at 24 h, the LDH activity was significantly 
higher in all treatment groups except for poly I:C and LOX.   The 24 h conditioned media 
including that of control groups had higher LDH activities at 24 h point compared with 6 
h (Fig 8). 
 
DISCUSSION  
Thymosin β4 is a ubiquitously occurring peptide in eukaryotic cells which has been 
shown to exert a variety of extracellular effects including wound healing, angiogenesis, 
and tissue remodeling [6, 7, 25, 26].  Despite its diverse extracellular actions, the 
mechanism of its release into the extracellular fluid remains intriguing because the 
peptide lacks a signal sequence, which is essential of most secretory proteins and peptides 
[11]. Nonetheless, there are a handful of reports suggestive of its secretion to 
extracellular environment using bone marrow endothelial cells and myocardial cells in 
culture and Tβ4 is present in significant quantities in human wound and blister fluids [27-
29]. Our rationale to study Tβ4 release from macrophages was its abundance in these 
cells [12, 30, 31] and these cells when subjected to immunomodulation by TLR-agonists 
increase their secretory activities [32].  SILAC has been a very sensitive and quantitative 
mass spectrometric method to measure the changes in peptide levels using corresponding 
MALDI MS signal ratio of light (L) and heavy (H) labeled peptide ions [33, 34]. 
Labeling with H (13C) and L (12C) lysine showed 9 Da difference  consistent with the 9 
lysine residues present in mature chicken Tβ4 as expected and the ratio of the MALDI 
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signal of these ions were monitored to determine the expression differences as shown in 
Fig 4 [12].  Our results however, showed any discernible change in neither cellular nor 
conditioned media associated Tβ4 at 6h time point in any treatment group. By contrast, a 
significant decrease in cellular Tβ4 was evident at 24 h time point in cultures treated with 
PGN, LPS, PAM, and CpG. Both L and H Tβ4 as well as their corresponding oxidized 
forms (Tβ4 sulfoxide) with additional mass difference of 16 Da due to oxidation of 
methionine [35] were detected in the conditioned media after 24 h treatment. 
Interestingly the Tβ4 sulfoxide appeared to be the dominant form in the conditioned 
media. The Tβ4 sulfoxide formation may be related to macrophage respiratory burst 
resulting from their activation (Rath et al., 2003).  Tβ4 sulfoxide ostensibly acts as an 
antioxidant that appeases inflammation [35-37].  
Based on 24 h result, it was clear that at least some TLR agonists are able to 
induce release of Tβ4 into the culture media implying that similar mechanisms may be 
operative in vivo leading to its accumulation in extracellular fluids under inflammatory 
conditions. Hence, we asked if Tβ4 was released by secretion induced by the above 
agonists, then it should be replenished in the cells that could be evident by assessing the 
changes in Tβ4 gene expression.  Along with Tβ4, we also monitored the expression of 
Il-1β, Il-6, and iNOS genes at 6 h time point as the measures of macrophage activation, 
and the changes in nitrite levels of cell culture supernatant at 24 h. The results showed 
that none of the agonists were able to modulate the expression of Tβ4 gene whereas PGN, 
LPS, PAM and CpG caused significant stimulation in the expression of Il-1β, Il-6, and 
iNOS genes and induced nitrite release that was consistent with the macrophage 
activation [19]. The changes in mRNA expression are generally considered to reflect the 
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changes in their respective proteins or peptides. In the absence of any detectable changes 
in Tβ4 gene expression, at the same time the observed intracellular and extracellular 
changes in the levels of this peptide suggested that cell damage may be a factor leading to 
its release into the cell conditioned media. LDH leakage into the extracellular medium is 
used as an indicator for the loss of cell viability which is caused by cytoplasmic 
membrane damage leading to cell death [24]. Therefore, we measured the changes in 
LDH levels in cell culture media, which showed is significant increase in culture media 
in those groups which showed the loss of cellular Tβ4 at 24 h.  It is likely that 
macrophage apoptosis is induced at 24 h by the action of those TLR agonists causing the 
leakage of Tβ4 into the conditioned medium. In fact, there are several reports, which 
show that both gram-positive and gram-negative microbial products such as PGN and 
LPS induce macrophage apoptosis [38-40].     
In conclusion our studies demonstrate that immunomodulatory and inflammatory 
agents affect the release of Tβ4 into extracellular environment that is induced by cellular 
damage. We believe this finding provides a mechanism for the release of Tβ4 into wound 
environment facilitating healing of injured or damaged tissues. 
 
ACKNOWLEDGEMENTS  
Thanks are due to Sonia Tsai, Scott Zornes, and Dana Bassi for technical assistance. 
 
 
 
 
 121 
 
REFERENCES 
1. Goldstein, A.L. (2007) History of the discovery of the thymosins. Ann. N. Y. 
Acad. Sci. 1112, 1-13. 
 
2. Huff, T., Muller, C.S., Otto, A.M., Netzker, R., Hannappel, E. (2001) beta-
Thymosins, small acidic peptides with multiple functions. In.t J. Biochem. Cell 
Biol. 33, 205-20. 
 
3. Safer, D., Elzinga, M., Nachmias, V.T. (1991) Thymosin beta 4 and Fx, an actin-
sequestering peptide, are indistinguishable. J. Biol. Chem. 266, 4029-32. 
 
4. Sun, H.Q., Kwiatkowska, K., Yin, H.L. (1995) Actin monomer binding proteins. 
Curr. Opin. Cell Biol. 7, 102-10. 
 
5. Smart, N., Rossdeutsch, A., Riley, P.R. (2007) Thymosin beta4 and angiogenesis: 
modes of action and therapeutic potential. Angiogenesis. 10, 229-41. 
 
6. Malinda, K.M., Sidhu, G.S., Mani, H., Banaudha, K., Maheshwari, R.K., 
Goldstein, A.L., Kleinman, H.K. (1999) Thymosin beta4 accelerates wound 
healing. J. Invest. Dermatol. 113, 364-8. 
 
7. Goldstein, A.L., Hannappel, E., Kleinman, H.K. (2005) Thymosin beta4: actin-
sequestering protein moonlights to repair injured tissues. Trends Mol. Med. 11, 
421-9. 
 
8. Philp, D., Goldstein, A.L., Kleinman, H.K. (2004) Thymosin beta4 promotes 
angiogenesis, wound healing, and hair follicle development. Mech. Ageing Dev. 
125, 113-5. 
 
9. Tang, Y.Q., Yeaman, M.R., Selsted, M.E. (2002) Antimicrobial peptides from 
human platelets. Infect. Immun. 70, 6524-33. 
 
10. Smith, J., Speed, D., Law, A.S., Glass, E.J., Burt, D.W. (2004) In-silico 
identification of chicken immune-related genes. Immunogenetics. 56, 122-33. 
 
11. Mannherz, H.G., Hannappel, E. (2009) The beta-thymosins: Intracellular and 
extracellular activities of a versatile actin binding protein family. Cell Motil. 
Cytoskeleton. 
 
12. Kannan, L., Rath, N.C., Liyanage, R., Lay, J.O., Jr. (2007) Identification and 
characterization of thymosin beta-4 in chicken macrophages using whole cell 
MALDI-TOF. Ann. N. Y. Acad. Sci. 1112, 425-34. 
 
 122 
13. Ross JA, A.M. (2002) In: The Macrophage. In The biology of the macrophage (L. 
C. Burke B, ed) Oxford University Press Oxford. U.K. pp 1-72. 
 
14. Rath, N.C., Kannan, L., Liyanage, R., Lay, J.O. (2007) Thymosin beta in 
macrophage. J. Endocrinol. Reprod. 11, 55-61. 
 
15. Crowther, M., Brown, N.J., Bishop, E.T., Lewis, C.E. (2001) Microenvironmental 
influence on macrophage regulation of angiogenesis in wounds and malignant 
tumors. J. Leukoc. Biol. 70, 478-90. 
 
16. Kaisho, T., Akira, S. (2006) Toll-like receptor function and signaling. J. Allergy 
Clin. Immunol. 117, 979-87; quiz 988. 
 
17. Hume, D.A. (2006) The mononuclear phagocyte system. Curr. Opin. Immunol. 
18, 49-53. 
 
18. Xie, H., Raybourne, R.B., Babu, U.S., Lillehoj, H.S., Heckert, R.A. (2003) CpG-
induced immunomodulation and intracellular bacterial killing in a chicken 
macrophage cell line. Dev. Comp. Immunol. 27, 823-34. 
 
19. Rath, N.C., Parcells, M.S., Xie, H., Santin, E. (2003) Characterization of a 
spontaneously transformed chicken mononuclear cell line. Vet. Immunol. 
Immunopathol. 96, 93-104. 
 
20. Ong, S.E., Mann, M. (2006) A practical recipe for stable isotope labeling by 
amino acids in cell culture (SILAC). Nat. Protoc. 1, 2650-60. 
 
21. Kannan, L., Liyanage, R., Lay, J.O., Jr., Rath, N.C. (2009) Evaluation of beta 
defensin 2 production by chicken heterophils using direct MALDI mass 
spectrometry. Mol. Immunol. 46, 3151-6. 
 
22. Kogut, M.H., Iqbal, M., He, H., Philbin, V., Kaiser, P., Smith, A. (2005) 
Expression and function of Toll-like receptors in chicken heterophils. Dev. Comp. 
Immunol. 29, 791-807. 
 
23. Kannan, L., Rath, N.C., Liyanage, R., Lay, J.O., Jr. (2009) Direct screening 
identifies mature beta-defensin 2 in avian heterophils. Poult. Sci. 88, 372-9. 
 
24. Vanderlinde, R.E. (1985) Measurement of total lactate dehydrogenase activity. 
Ann. Clin. Lab Sci. 15, 13-31. 
 
25. Grant, D.S., Rose, W., Yaen, C., Goldstein, A., Martinez, J., Kleinman, H. (1999) 
Thymosin beta4 enhances endothelial cell differentiation and angiogenesis. 
Angiogenesis. 3, 125-35. 
 
 123 
26. Sosne, G., Szliter, E.A., Barrett, R., Kernacki, K.A., Kleinman, H., Hazlett, L.D. 
(2002) Thymosin beta 4 promotes corneal wound healing and decreases 
inflammation in vivo following alkali injury. Exp. Eye Res. 74, 293-9. 
 
27. Frohm, M., Gunne, H., Bergman, A.C., Agerberth, B., Bergman, T., Boman, A., 
Liden, S., Jornvall, H., Boman, H.G. (1996) Biochemical and antibacterial 
analysis of human wound and blister fluid. Eur. J. Biochem. 237, 86-92. 
 
28. Huang, W.Q., Wang, Q.R. (2001) Bone marrow endothelial cells secrete 
thymosin beta4 and AcSDKP. Exp. Hematol. 29, 12-8. 
 
29. Bock-Marquette, I., Saxena, A., White, M.D., Dimaio, J.M., Srivastava, D. (2004) 
Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell 
migration, survival and cardiac repair. Nature. 432, 466-72. 
 
30. Gondo, H., Kudo, J., White, J.W., Barr, C., Selvanayagam, P., Saunders, G.F. 
(1987) Differential expression of the human thymosin-beta 4 gene in 
lymphocytes, macrophages, and granulocytes. J. Immunol. 139, 3840-8. 
 
31. Hannappel, E., Xu, G.J., Morgan, J., Hempstead, J., Horecker, B.L. (1982) 
Thymosin beta 4: a ubiquitous peptide in rat and mouse tissues. Proc. Natl. Acad. 
Sci. U S A. 79, 2172-5. 
 
32. Serhan, C.N., Brain, S.D., Buckley, C.D., Gilroy, D.W., Haslett, C., O'Neill, L.A., 
Perretti, M., Rossi, A.G., Wallace, J.L. (2007) Resolution of inflammation: state 
of the art, definitions and terms. FASEB J. 21, 325-32. 
 
33. Ong, S.E., Blagoev, B., Kratchmarova, I., Kristensen, D.B., Steen, H., Pandey, A., 
Mann, M. (2002) Stable isotope labeling by amino acids in cell culture, SILAC, 
as a simple and accurate approach to expression proteomics. Mol. Cell. 
Proteomics. 1, 376-86. 
 
34. Ong, S.E., Mann, M. (2007) Stable isotope labeling by amino acids in cell culture 
for quantitative proteomics. Methods Mol. Biol. 359, 37-52. 
 
35. Chettibi, S., Lawrence, A.J., Young, J.D., Lawrence, P.D., Stevenson, R.D. 
(1994) Dispersive locomotion of human neutrophils in response to a steroid-
induced factor from monocytes. J. Cell Sci. 107 ( Pt 11), 3173-81. 
 
36. Jain, A.K., Moore, S.M., Yamaguchi, K., Eling, T.E., Baek, S.J. (2004) Selective 
nonsteroidal anti-inflammatory drugs induce thymosin beta-4 and alter actin 
cytoskeletal organization in human colorectal cancer cells. J. Pharmacol. Exp. 
Ther. 311, 885-91. 
 
37. Young, J.D., Lawrence, A.J., MacLean, A.G., Leung, B.P., McInnes, I.B., Canas, 
B., Pappin, D.J., Stevenson, R.D. (1999) Thymosin beta 4 sulfoxide is an anti-
 124 
inflammatory agent generated by monocytes in the presence of glucocorticoids. 
Nat. Med. 5, 1424-7. 
 
38. Soler, C., Valdes, R., Garcia-Manteiga, J., Xaus, J., Comalada, M., Casado, F.J., 
Modolell, M., Nicholson, B., MacLeod, C., Felipe, A., Celada, A., Pastor-
Anglada, M. (2001) Lipopolysaccharide-induced apoptosis of macrophages 
determines the up-regulation of concentrative nucleoside transporters Cnt1 and 
Cnt2 through tumor necrosis factor-alpha-dependent and -independent 
mechanisms. J. Biol. Chem. 276, 30043-9. 
 
39. Marriott, H.M., Ali, F., Read, R.C., Mitchell, T.J., Whyte, M.K., Dockrell, D.H. 
(2004) Nitric oxide levels regulate macrophage commitment to apoptosis or 
necrosis during pneumococcal infection. FASEB J. 18, 1126-8. 
 
40. Xaus, J., Comalada, M., Valledor, A.F., Lloberas, J., Lopez-Soriano, F., Argiles, 
J.M., Bogdan, C., Celada, A. (2000) LPS induces apoptosis in macrophages 
mostly through the autocrine production of TNF-alpha. Blood. 95, 3823-31. 
 
 
 
 125 
Table 1: Primer sequences used in Q-PCR [12, 19]. 
 
RNA 
target 
Forward primer (5’ to 3’) Reverse primer (5’ to 3’) Accession number 
β- actin CCATGAAACTACCTTCAACTCCA GATTCATCGTACTCCTGCTTGCT L08165 
IL-6 CTCCTCGCCAATCTGAAGTC TCATAGAGACGCTGCTGCCAG AJ309540 
iNOS AGGCCAAACATCCTGGAGGTC TCATAGAGACGCTGCTGCCAG U46504 
IL-1β GGCTCAACATTGCGCTGTAC CCCACTTAGCTTGTAGGTGGC Y15006 
Tβ4 GCCGAGATCGAGAAATTTGA GAAGGCAATGCTTGTGGAAT NM_001001315 
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FIGURE LEGENDS 
Figure 1. A flow chart illustrating SILAC method to study the effects of different TLR 
ligands on Tβ4 production by HTC cells. 
Figure 2. MALDI-MS profiles of 1:1 cell lysate mixtures containing light (L) and heavy 
(H) lysine labeled Tβ4 after 6 h stimulation with TLR agonists.   
Figure 3. MALDI-MS profiles of 1:1 cell lysate mixtures containing light (L) and heavy 
(H) lysine labeled Tβ4 after 24 h stimulation with TLR agonists.   
Figure 4. MALDI-MS profiles of 1:1 supernatant extract mixtures containing light (L) 
and heavy (H) lysine labeled Tβ4 after 24 h stimulation with TLR agonists.  
Figure 5. Relative changes in the cellular Tβ4 induced by TLR agonists at 6 and 24 h. 
Data represent the mean value ± SEM for triplicates samples in each groups from three 
independent experiments (n=9). ** Indicates p ≤ 0.0001 and * is p ≤ 0.005. 
Figure 6. Q-PCR gene expression results after 6 h stimulation of HTC cells by different 
TLR agonists. The results represent an average of duplicate experiments. 
Figure 7. Changes in nitrite production at 6 and 24 h time point induced by TLR agonists 
in HTC cells. * Indicates p ≤  0.0001. 
Figure 8. Cell viability changes measured by LDH activity at 6 and 24 h.  ** Indicates p 
≤ 0.0001 and * is p ≤ 0.005. 
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Figure 1. 
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Figure 2. 
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Figure 3.  
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Figure 4. 
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Figure 5.  
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Figure 6.   
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Figure 7.  
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Figure 8.  
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ABSTRACT  
Beta defensins (BD) are cysteine rich, cationic antimicrobial peptides (AMP) produced 
mainly by epithelial and myeloid cells such as neutrophils. In birds, the neutrophil 
equivalent heterophils produce avian beta defensins (AvBD) of which AvBD2 is the 
major isoform. Heterophils recognize pathogens or their derived products through a series 
of pattern recognition receptors called toll-like receptors (TLR) leading to their 
antimicrobial activities. This work is the first report of TLR modulation of AvBD2 
expression in chickens. To measure the effect of TLR activation on AvBD2 production, 
the heterophils were cultured with different TLR agonists for 6 h. Modulation of AvBD2 
levels by TLR activation was measured using direct MALDI mass spectrometry without 
stable isotopic labeling or chromatographic separation.  Chemical modification of the 
conditioned media was performed using reduction/alkylation with dithiothreitol and 
iodoacetamide to distinguish TLR treated AvBD2 (reduced/alkylated) from controls 
(non-reduced). Changes in corrected ion intensity ratios were assumed to reflect AvBD2 
modulation in heterophils upon activation with different TLR agonists. In general, TLR 
agonists increased AvBD2 production with LPS showing the greatest induction and CpG-
ODN showing little or no effect. These data show that the direct MALDI-MS coupled 
with reduction/alkylation may provide a rapid relative quantitative approach to the 
measurement of agonist-induced differential expression of AvBD2.  
Key words: avian beta defensin 2, heterophil, MALDI-TOF-MS, toll-like receptors 
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1. INTRODUCTION 
Antimicrobial peptides are the efferent arms of innate immunity that play a vital role in 
host defense mechanisms by neutralizing microbial pathogens (Boman, 1995; Hancock, 
2001). The defensins are an important class of these peptides that have been identified 
and characterized in many species including plants, invertebrates, and vertebrates 
(Brogden et al., 2003; Ganz, 2005; Zasloff, 2002). The vertebrate defensins contain three 
pairs of intramolecular disulfide bonds and are classified into subfamilies of α, β, and θ 
depending on the positions of their cysteine residues and the disulfide bond connectivity 
(Ganz, 2005; Klotman and Chang, 2006; Selsted and Ouellette, 2005). However, the 
avian species only express beta defensins and to date, there are 14 known isoforms of 
avian beta defensins in chicken and few orthologs in other species of birds (Lynn et al., 
2004; Lynn et al., 2007; Sugiarto and Yu, 2006; van Dijk et al., 2008; Xiao et al., 2004). 
Whereas these AvBDs have been predicted using genomic and bioinformatics 
approaches, only a few corresponding peptides have been isolated (Evans et al., 1994; 
Harwig et al., 1994; Kannan et al., 2009; Sugiarto and Yu, 2006; Thouzeau et al., 2003). 
The avian leukocyte, heterophils, play a central role in innate immunity during acute 
phase response and microbial infection (Harmon, 1998; Kaiser, 2007).  These cells use 
their surface receptors, called ‘Toll-like receptors’ (TLR) to discriminate microbial 
motifs called ‘pathogen-associated molecular patterns’ (Janeway and Medzhitov, 2002; 
Sabroe et al., 2003). TLR activation triggers immune responses resulting in the 
expression of effectors such as cytokines, chemokines, and antimicrobial factors 
including beta defensins (Boyd et al., 2007; Kogut et al., 2005; Kogut et al., 2006). 
Although there are several studies on the expression profiles and antimicrobial activities 
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of AvBDs, there is a limited knowledge of TLR activation and resultant beta defensin 
expression. Most studies on the regulation of AvBD have employed RT-PCR which can 
detect gene expression, but not subsequent peptide production (Akbari et al., 2008; 
Milona et al., 2007; Subedi et al., 2007; van Dijk et al., 2008). To date, we know of no 
study on the TLR activation induced expression of BD at the peptide level in avian 
species. Our earlier studies using direct screening of phagocytes and bone marrow of 
chickens and turkeys, by matrix-assisted laser desorption/ionization time-of-flight mass 
spectrometry (MALDI-TOF-MS), showed avian beta defensin 2 (AvBD2) as an abundant 
peptide present in heterophils (Kannan et al., 2009). Thus, the objective of the current 
study was to find whether TLR activation would induce changes in the production of 
AvBD2 by heterophils. In recent years, MS has been used to measure differential 
expression of proteins and peptides. MS approaches include direct intensity based 
measurements and methods based on differential labeling of proteins using stable 
isotopes such as SILAC (stable isotope labeling of amino acids in cell culture), isotope-
coded affinity tag (ICAT), and isobaric tag for relative and absolute quantitation 
(iTRAQ) reagents (Gygi et al., 1999; Ong and Mann, 2007; Wiese et al., 2007; Yan and 
Chen, 2005). Herein, we report a simple and an inexpensive method to determine the 
changes in AvBD2 production by heterophils induced by TLR agonists, using differential 
chemical labeling (reduction/alkylation) followed by MALDI-TOF-MS.  
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2. MATERIALS AND METHODS 
2.1. Chemicals and reagents 
One Step PolymorphTM medium (Accurate Chemicals Co, Westbury, NY), K-EDTA 
Vacutainer tubes (BD Bioscience, Franklin, NJ), RPMI-1640 medium (Mediatech Inc., 
Herndon, VA), C18 ZipTip micropipette tips (Millipore, Billerica, MA), peptide 
calibration standards of 500-5000 Da (Bruker Daltonics, Bremen, Germany), BioRad dye 
binding reagent  (Bio-Rad, Hercules, CA), TLR agonists such as synthetic lipoprotein 
Pam3CSK4 (palmitoyl-3-cysteine-serine-lysine-4; PAM), Salmonella typhimurium 
flagellin (FGN), and guanine analog loxoribine (LOX) (Invivogen, San Diego, CA) were 
purchased.  The Streptococcal pyrogenes peptidoglycan (PGN) was a gift from BD 
Bioscience (San Jose, CA). The CpG-oligodeoxynucleotide (CpG-ODN 2006), 
corresponding to the sequence TCGTCGTTTTGTCGTTTTGTCGTT (Xie et al., 2003), 
was synthesized by Invitrogen (Carlsbad, CA). All other reagents including Salmonella 
typhimurium lipopolysaccharide (LPS), synthetic dsRNA analog poly I:C, bovine serum 
albumin (BSA), fluorescein isothiocyanate (FITC),  propidium iodide (PI), 1,4- 
dithiothreitol (DTT), 2-iodoacetamide (IAA), and 2,5- dihydroxybenzoic acid (DHB) 
were purchased from Sigma Aldrich (St. Louis, MO).   
 
2.2. Isolation of chicken blood heterophils 
All animal procedures were approved by the University of Arkansas animal care and use 
committee. Blood was obtained from ten three week-old broiler chickens by cardiac 
puncture using K-EDTA Vacutainer tubes prior to killing. The K-EDTA anti coagulated 
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blood was subjected to centrifugation over One Step PolymorphTM gradient at 500 X g 
for 20 min. After removing the mononuclear cell layer at the inter phase of serum and the 
density gradient medium, the cells were further centrifuged for another 30 min to band 
the heterophils in the gradient and pellet red blood cells to the bottom. The bands rich in 
heterophil granulocytes, were washed following manufacturer’s suggested protocol, 
pooled, and finally suspended in RPMI-1640 media containing 0.2% BSA. The viability 
and the purity of heterophils were determined by trypan blue exclusion and staining of 
cytocentrifuged cells with fluorescein isothiocyanate and propidium iodide respectively 
(Rath et al., 1998). The viability of the cells was determined to be more than 98%.  
 
2.3. Activation of heterophils by TLR agonists 
The heterophils were distributed at a concentration of 1 x 105 cells/ ml/ well in 12 well 
plates and cultured in triplicate with different TLR agonists for 6 h at 370C. Different 
ligands, TLR1/2: peptidoglycan (PGN), TLR3: poly inosinic cytidylic acid (poly I:C), 
TLR4: gram negative bacterial lipopolysaccharide (LPS), TLR5: bacterial flagellin 
(FGN), TLR1/6: PAM3CSK4, TLR7: loxoribine; and TLR9: CpG-ODN, were prepared 
at 100X concentrations in RPMI-1640 medium and added to the cultures.  TLR agonists 
may elicit a response by different mechanisms and they have different active 
concentrations. In order to be reasonably certain that these agonists would elicit 
heterophil activation and also the differential expression of AvBD2, concentrations of the 
TLR agonists were selected based on values recommended by the suppliers and in the 
literature (Kogut et al., 2005; Xie et al., 2003).  The final concentrations of the TLR 
agonists were PAM (1µg/ml), PGN (1 µg/ml), FGN (1 µg/ml), poly I:C (1 µg/ml), LOX 
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(100µM), CpG-ODN (1µM) and LPS (1 µg/ml).  The control cultures received the 
diluent media only.  
 
2.4. Sample preparation 
After 6 h of stimulation, the conditioned media were aspirated and spun at 1,000 X g for 
5 min to obtain supernatants free of cells and frozen at -200C for subsequent use. Aliquots 
of the conditioned media were mixed with equal volumes of 100% methanol containing 
2% acetic acid to denature and precipitate proteins over a 16 h period at 40C, and 
centrifuged at 21,000 X g for 10 min to obtain the supernatant extract containing AvBD 
(Kannan et al., 2009). The residual protein concentrations of the media were measured 
using a BioRad dye binding assay in order to equalize the protein content of different 
samples if necessary.  
 
2.5. Chemical modification 
Aliquots of supernatant extract from different TLR treatment (T) groups were subjected 
to reduction for 1 h with 10 mM 1,4-dithiothreitol (DTT) followed by alkylation with 20 
mM 2-iodoacetamide (IAA) in dark for 25 min at 370C. Equivalent aliquots of both 
control (C) and treated samples were also subjected to similar conditions but without 
DTT/IAA additions. Thus, each group consisted of non-reduced (nr) and 
reduced/alkylated (r) samples based on their chemical treatments, Cnr, Cr, Tnr, and Tr 
respectively, (Fig. 1). They were used not only to calculate correction factors (CF) for 
individual groups but also to determine the relative changes in AvBD2 production due to 
treatments as described below. 
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2.6. Direct MALDI-MS analysis 
For MALDI measurements, microliter volumes of sample were mixed 1:1 with 1M DHB, 
prepared in 90% methanol containing 0.1 % formic acid. Two µl of this mixture was 
spotted onto a Bruker MTP 384 MALDI target. Calibrated MALDI-TOF spectra were 
acquired over the m/z range from about 1-10 kDa in the positive ion reflector mode using 
either a Bruker Reflex III MALDI-TOF or a Bruker Ultraflex II MALDI-TOF-TOF MS 
(Bruker Daltonik GMBH, Bremen, Germany). Samples were analyzed in both manual 
and automation modes. The data were processed using Bruker Flex Analysis 2.4/3.0 and 
ClinProTools 2.2 softwares. 
The samples were initially screened for the presence of AvBD2 by searching for 
ion signal at m/z 3916 indicated by its protonated intact ion. After confirmation of the 
presence of AvBD2, aliquots of the TLR agonist treated samples were reduced/alkylated 
to produce a characteristic mass shift of 348 Da to produce m/z 4264 that would 
differentiate them from the controls. The efficacy of this chemical modification was also 
confirmed by MALDI-MS. The control and treated samples were then mixed 1:1 for the 
determination of differential expression of AvBD2. 
 
2.7. Determination of correction factor (CF) 
Our procedure compares the signal intensities of AvBD2 peptides that are 
reduced/alkylated or are not.  This approach assumes that the peak heights for the 
protonated molecules reflect the quantity of these AvBD2 species in modified and non-
modified samples. However, the ionization efficiency of the two peaks can be affected by 
the complex environment, necessitating the use of correction factors (CF) estimated for 
 144 
each group, CFC for control and CFT for treatments. Therefore, each sample split 
consisting of equal amounts of reduced/alkylated and non-reduced AvBD2 were mixed 
so that the theoretical intensity ratios would be 1. This 1:1 mixture was then subjected to 
direct MALDI-MS analysis and the actual intensity ratios of reduced/alkylated over non-
reduced AvBD2 peaks (Cr/Cnr & Tr/Tnr) were measured for controls and each of the 
individual treatments as described in Fig. 1.  Accordingly, the correction factors were 
calculated based on six mass measurements obtained from triplicate samples, CFC = 
Cnr/Cr  and CFT = Tnr/Tr. CFC corrects for the differences in ionization efficiency due to 
reduction/alkylation, whereas CFT corrects for the differences due to reduction/alkylation 
and the presence of TLR agonists. Since CFT takes care of both the factors that may 
influence the ionization efficiency of AvBD2, we consider the use of only CFT in the 
formula for calculating the relative changes in AvBD2 production.  
 
2.8. Relative changes in AvBD2 
Based on the peak intensities observed in the mass spectrum for reduced/alkylated and 
non-reduced AvBD2, the intensity ratios (Tr /Cnr) were calculated for all treatment 
groups. Relative changes in AvBD2 production were determined by multiplying the 
intensity ratio (Tr /Cnr) with appropriate correction factors CFT for each treatment group 
(Fig. 1).  The mean and standard error of the mean (SEM) was calculated from six mass 
measurements obtained using triplicate samples. The differences were determined using 
students t-test and a P-value ≤ 0.05 was considered statistically significant.  
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3. RESULTS AND DISCUSSION 
Defensins are important mediators of innate immunity; hence, there is a considerable 
interest in measuring their changes under a variety of conditions which challenge 
immunity.  However, the occurrence of different isoforms of beta defensins which in 
chicken alone numbers upto 14 variants (Lynn et al., 2007; van Djik et al., 2008), has 
precluded the development of some common immunoassays that may be broadly 
applicable to all of them. In fact, commercially available immunoassays of defensins are 
largely limited to mammalian species (Gardner et al., 2009; Ghosh et al., 2007). 
Consequently, RT-PCR has been the method of choice for most AvBD related studies, 
which measure the changes in mRNA populations. However, incongruency in the 
expression levels of mRNA and proteins that may relate to alternative splicing, post 
transcriptional gene silencing and protein modifications can preclude accurate estimation 
of changes at the peptide level. Therefore, the current method may be suitable to measure 
the changes in BD levels using simple chemical modification of their highly conserved 
cysteine residues rather than more expensive stable isotope methods.  
Our results show that the heterophils constitutively produce AvBD2 as evident 
from the protonated ion observed in direct MALDI-MS spectra (Fig. 2) (Kannan et al., 
2009).  Generally, in mass spectrum the signal intensity of the peaks reflect the quantity 
of materials present; however, the experimental conditions and chemical modifications 
can alter the ionization efficiency of the peaks (Guerrera and Kleiner, 2005; Yan and 
Chen, 2005). Therefore, we checked to determine whether the ionization efficiency of the 
reduced/alkylated and non-reduced AvBD2 were identical. AvBD2 containing samples 
(treated and controls) were split and half of the sample was reduced/alkylated, before 
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remixing to measure the different signal levels for nominally identical quantities of both 
forms of AvBD2 in the same sample. The prominent ion corresponding to AvBD2 (m/z 
3916) shifted in reduced/alkylated samples by 348 Da, showing complete 
carbamidomethylation of 6 cysteine residues resulting in the mass of 4264 (Fig. 3a, b). In 
general, carbamidomethylation is an efficient and reliable chemical modification method 
widely used in many proteomic studies (Simpson, 2003). In this experiment, we 
confirmed the labeling to be 100%, with no trace of non-reduced AvBD2 in the TLR 
agonist treated samples. Fig. 4a shows a MALDI spectrum for a 1:1 mixture of non-
reduced and reduced/alkylated forms of AvBD2 in the control sample whereas Fig. 4b to 
4h show spectra for a 1:1 mixture of the control (non-reduced) and TLR agonist treated 
(reduced/alkylated) samples. The peak at m/z 3916 represents AvBD2 in untreated 
control group whereas the peak at m/z 4264 corresponds to the reduced/alkylated AvBD2 
from the treated sample. Changes in relative intensity ratios of m/z 4264 and m/z 3916 are 
taken to reflect the changes in AvBD2 production induced by different TLR agonists. 
However, it is evident that the intensity ratio obtained directly from the MALDI spectra 
does not truly represent AvBD2 populations. Therefore, correction factors were estimated 
to calculate the changes in the ionization efficiency of AvBD2 due to both 
reduction/alkylation and presence of TLR agonists. The average CF and the SEM for 
different groups were as follows; controls, 1.5 ± 0.1; PGN, 2.0 ± 0.1; Poly I:C, 2.2 ± 0.2; 
LPS, 2.2 ± 0.2; FGN, 1.8 ± 0.3; PAM, 1.5 ± 0.1; LOX, 2.2 ± 0.3; and CpG, 2.0 ± 0.1. 
 The overall results show that most TLR agonists increased the secretion of 
AvBD2 by heterophils albeit to different extents except for CpG-ODN which showed no 
change (Fig. 5). The inability of CpG-ODN to incite production of AvBD2 may be that, it 
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is not a potent inflammatory agent in the concentration used in this study or due to the 
absence of TLR 9 receptor in chickens for which it acts as a ligand (Boyd et al., 2007; 
Dar et al., 2009; Kogut et al., 2006; Temperley et al., 2008). However, many studies 
using CpG-ODN in poultry models have shown it to activate of both macrophages and 
heterophils (Xie et al., 2003; Kogut et al., 2006).  Therefore, the inability of CpG-ODN to 
induce AvBD2 remains unexplained. LPS is a potent inflammatory agent, which induced 
maximal changes in AvBD2 production (P≤0.001); others such as PGN, PAM, FGN, 
LOX and poly I:C also showed significant increase in its production (P≤0.05) consistent 
with their efficacies to activate heterophils (Kogut et al., 2005).  
  Quantitative analysis of human defensins by mass spectrometry has been reported 
using polyacrylamide gel electrophoresis, heavy stable isotope labeling, liquid 
chromatography, and electro spray ionization (ESI) mass spectrometry (Jorgensen et al., 
2006; Thompson et al., 2006; Zhou et al., 2002). The advantage of the current procedure 
is that the measurement of the relative changes in BD can be achieved without stable 
isotope labeling or liquid chromatography and the assay can be performed directly and 
quickly in complex mixtures.  
 In conclusion, these results demonstrate that the method of chemically modifying 
AvBD without stable isotope tagging followed by direct MALDI-TOF-MS analysis may 
be a suitable and inexpensive method to study their differential expression. This general 
method of relative quantification can likely be adopted for any system where peptide of 
interest contains at least one cysteine residue.   
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FIGURE LEGENDS 
Figure 1: A flowchart showing the experimental protocol to determine the relative 
changes in AvBD2 production by chicken heterophils upon TLR activation. 
Figure 2: MALDI-TOF spectral profiles of heterophil conditioned media extract 
prepared from control and TLR agonist treated cultures showing AvBD2 peak (m/z 
3916). 
Figure 3: MALDI-TOF mass spectra of heterophil conditioned media extracts showing 
AvBD2 peaks (a) without reduction and alkylation and (b) after reduction and alkylation.  
Figure 4: MALDI-TOF-MS profiles of 1:1 mixture of non-reduced and reduced AvBD2 
forms. (a) control sample showing both non-reduced (m/z 3916) and reduced (m/z 4264) 
and (b) to (h) represent equivalent mixtures of control non-reduced (m/z 3916) and TLR 
agonist treated reduced (m/z 4264) AvBD2.  
Figure 5: Relative changes in the production of AvBD2 by heterophils induced by 
different TLR agonists compared with control. Data represents the mean value ± SEM for 
six mass measurements from triplicates samples in each groups. * indicates significant 
statistical differences with control p≤0.05 and ** represents p≤0.001.   
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CONCLUSION 
Owing to the ubiquitous role of peptides in many physiological processes as 
hormones, neurotransmitters, growth and antimicrobial factors, we hypothesized that 
many such peptides occur as native components of cells as part of its specialized 
functions and peptide levels are likely regulated under physiological demand. 
We used avian mononuclear cells/macrophages and heterophils as models of 
specialized cells that are central components of innate immunity. Using matrix assisted 
laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry we screened 
whole cells and their extracts to determine similarities and differences in their spectral 
profiles. The high intensity mass spectral peaks were used as the criteria of selection to 
identify and characterize the corresponding peptides from each of the above cell 
populations. Then the quantitative changes in peptide levels were studied under TLR 
activation of these cells mimicking immunomodulation.  
Screening mononuclear cells, transformed avian macrophages, and heterophils 
identified a high intensity spectrum corresponding to m/z 4963 expressed differentially in 
mononuclear cell but not in heterophil populations which exhibited its specific profiles.  
Using proteomic approaches such as reverse phase high performance liquid 
chromatography-electrospray ionization, N-terminal sequencing, and peptide mass 
fingerprint, m/z 4963 was identified as thymosin beta 4 (Tβ4), an actin binding peptide.  
The mature form of the peptide identified was found to be modified and had lower mass 
than that predicted from its corresponding genomic sequence (Chapter 2). Similarly, we 
identified and characterized avian beta defensin 2 (AvBD2), as an abundantly occurring 
antimicrobial peptide in heterophils of both chickens and turkeys with 90% sequence 
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homology (Chapter 3). The study on beta defensins was extended to two other related 
avian species, pheasant and quail. Chapter 4 deals with reduction and alkylation 
approach, incorporated to general MALDI screening strategy, to selectively screen 
peptides having 6 cysteine residues followed by mass spectrometric fragmentation 
method to sequence the peptide. The approach proved to be rapid in place of time-
consuming HPLC isolation and MALDI peptide mass fingerprinting (PMF) method. The 
study yielded the mature peptide sequences of pheasant and quail orthologs of AvBD2 
(Chapter 4). This is the first report of these peptides in pheasant and quail. These results 
demonstrate that MALDI-TOF is a potential tool to rapidly screen and detect low 
molecular weight proteins and peptides associated with cells, tissues, and biological 
fluids that cannot be resolved by 2-D gel electrophoresis. Also, these studies show that a 
simple, rapid and direct screening of crude extracts by MALDI-TOF-MS can detect 
important homologous peptides relevant to disease or other peptidomic endpoints, even 
across species lines. 
Tβ4 is an anti inflammatory peptide involved in tissue remodeling, angiogenesis 
and wound healing while avian beta defensins are antimicrobial peptides although their 
other physiological roles are not completely understood. AvBD2 has been suggested to 
act as an immunomodulator and anti inflammatory factor. Thus it postulates that these 
peptides need to be regulated under conditions, which evoke an innate immune activity. 
A reasonable assumption with reference to the regulatory mechanisms of these peptides 
can be related to Toll like receptors (TLR). The TLRs are the primary sensors of innate 
immunity acting as the pattern recognition molecules on the surface of both 
monocytes/macrophages and heterophils. Recognition of different ligands derived from 
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different pathogen sources such as bacteria, virus, parasites, and fungi can elicit both 
common and separate immune responses. Thus, the recognition of these pathogens would 
lead to the activation of intracellular signaling pathways to modulate the production of 
these peptides along with other pro and/or anti inflammatory molecules. We studied to 
find the effects of different TLR agonists on the expression and production of Tβ4 in a 
chicken transformed macrophage cell line and AvBD2 in chicken blood heterophils using 
gene expression and peptide quantification as described in Chapters 5 and 6.  
Chapter 5 discusses the activation of different TLRs by corresponding agonists 
and their effects on Tβ4 production by chicken macrophages. In view, of its multiple 
effects such as wound healing, angiogenesis and tissue remodeling, the study was done to 
understand the mechanism of its release to the extracellular environment. Gene 
expression studies by real time PCR showed only few agonists, lipopolysaccharide, 
peptidoglycan, and synthetic lipoprotein PAM3CSK4, that stimulate activation of TLR 2, 
4, and TLR2/1 respectively, up-regulated the expression of Il-6, Il-1β and iNOS but had 
no effect on Tβ4. Stable isotope labeling with amino acids in the cell culture (SILAC) 
followed by mass spectrometry, to study Tβ4 secretion showed these ligands caused a 
significant decrease in cellular Tβ4 content at 24 h. The decrease was accompanied by a 
corresponding release of Tβ4 into the culture medium. In the absence of its synthesis, the 
release of Tβ4 into the culture medium appears to be associated with cell death as 
indicated by LDH measurements in the culture medium. These results imply that Tβ4 in 
extracellular fluid originates from dying cells rather than active secretions. This 
contributes to the understanding of the origin of Tβ4 in the wound fluids. 
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Chapter 6 describes a novel method to quantify AvBD2 production by heterophils 
under immunomodulating conditions of TLR activation. It uses chemical modification 
and mass spectrometric approach to measure the changes in AvBD2 levels. The results 
show significant differences among the different TLR agonist treatment groups in 
eliciting AvBD2 release into the culture medium with LPS having highest effect and the 
CpG showing no effect. Also peptidoglycan, PAM3CSK4, flagellin, and Poly I:C showed 
significant secretion of AVBD2. In the absence of an available immuno assay method for 
AvBDs, the current method which uses chemical modification of cysteinyl residues in 
BDs provides an approach to measure the relative levels of any AvBD isoforms in 
complex biological mixtures. This approach of modifying beta defensins and MALDI-
TOF-MS analysis appears to be a suitable tool which is simple, cost and time effective.  
These studies provide a paradigm of expression peptidomics of cells which likely 
are consequential for their physiology. Identifying and characterizing all cell or tissue 
associated peptides will provide better understanding of their functions and their 
application potentials.   
 
 
 
 
 
 
 
 
 
 162 
A BIOGRAPHICAL SKETCH- LAKSHMI KANNAN 
Education 
Aug 2009 Ph.D, Cell & Molecular Biology, University of Arkansas, Fayetteville, AR 
May 2004 M.Sc., Biotechnology, University of Madras, Chennai, India 
May 2002 B.Sc., Chemistry, University of Madras, Chennai, India 
Professional Experience 
Aug 2005- Aug 2009 Senior Graduate Research Assistant in the Cell & Molecular Biology 
Program, University of Arkansas, Fayetteville, AR  
 
Apr 2003-Sep 2003 Research Trainee in Department of Biochemistry,  
Indian Institute of Science, Bangalore, India 
 
Honors and Awards 
Dale Bumpers Distinguished Doctorate Scholar in the Dale Bumpers College of Agricultural, Food and 
Life Sciences, University of Arkansas (2009); First Place in oral presentation and second place in poster 
presentation at student research competition sponsored by Gamma Sigma Delta Honor Society, University 
of Arkansas (2009); received Student Travel Award from Arkansas Biosciences Institute (ABI) to 
participate and present in the ABI Fall Research Symposium, Little Rock, AR (2008); awarded a Certificate 
of Excellence for outstanding presentation in the immunology section at Poultry Science Association, 
Niagara Falls, Canada (2008); received Tom Sullivan Award for First Place in the scientific presentation at 
the Poultry Science Graduate Association Summer Symposium at Department of Poultry Science, 
University of Arkansas (2008); recipient of Student Travel Award from the Aegean International 
Conference to participate and present in the 5th International Conference on Innate Immunity at Crete, 
Greece (2008); awarded Certificate of Excellence for outstanding achievement in leadership, service, 
campus activities, and academics by a national program known as Who’s Who among Students in 
American Universities and Colleges, Center for Leadership and Community Engagement, University of 
Arkansas (2008); awarded First Place in the poster presentation sponsored by Gamma Sigma Delta Honor 
Society, University of Arkansas (2008); awarded a Certificate of Excellence for outstanding presentation in 
the immunology section at Poultry Science Association, San Antonio, TX (2007); awarded with a free 
Registration Grant to participate and present in the First International Symposium on Thymosin at 
Washington DC (2007); received Merit Scholarship during M.Sc. Biotechnology for the academic years, 
University of Madras, Chennai, India (200-2004); awarded the Best Outgoing Student during B.Sc. in 
Chemistry for the Academic years, University of Madras, Chennai, India (1999-2002); received merit of 
First Place in Physical Chemistry, University of Madras, Chennai, India (2002). 
 
Publications and Scientific Presentations 
Published 7 peer-reviwed papers, 3 as primary and 4 as co-author and 2 more as primary author are in the 
process of review. Number of  oral and poster presentations in international, national and regional meeting 
include 24.  
 
Academic and Professional Memberships  
American Association for the Advancement of Science, American Society of Mass Spectrometry,  
American Association of Immunology,  Poultry Science Association, Associate Member of Sigma Xi 
International Honor Society of Scientific and Engineering Research, University of Arkansas Chapter, 
Poultry Science Graduate Student Association. 
 
 
 
 163 
 
